(lp1
(dp2
S'cdsr_refcode'
p3
VSTD-Hansudewechakul--2012
p4
sS'pmc_id'
p5
S'PMC3494174'
p6
sS'cdsr_filename'
p7
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p8
sS'pm_filename'
p9
V23078768.xml
p10
sa(dp11
g3
VSTD-Humphreys-2010
p12
sg5
S'PMC2924332'
p13
sg7
g8
sg9
V20687955.xml
p14
sa(dp15
g3
VSTD-Fatti-2010
p16
sg5
S'PMC2943483'
p17
sg7
g8
sg9
V20877631.xml
p18
sa(dp19
g3
VSTD-Jaffar-2009
p20
sg5
S'PMC2806484'
p21
sg7
g8
sg9
V19939445.xml
p22
sa(dp23
g3
VSTD-Odafe-2012
p24
sg5
S'PMC3521762'
p25
sg7
g8
sg9
V23272094.xml
p26
sa(dp27
g3
VSTD-Payne-1960
p28
sg5
S'PMC3577661'
p29
sg7
VCD000284 v. 13.5 Chlorpromazine versus placebo for schizophrenia.rm5
p30
sg9
V23388243.xml
p31
sa(dp32
g3
VSTD-Lannin-2007
p33
sg5
S'PMC1832184'
p34
sg7
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p35
sg9
V17355644.xml
p36
sa(dp37
g3
VSTD-Spink-2011
p38
sg5
S'PMC3116775'
p39
sg7
g35
sg9
V21680622.xml
p40
sa(dp41
g3
VSTD-Haran-2010
p42
sg5
S'PMC2876235'
p43
sg7
g35
sg9
V20501583.xml
p44
sa(dp45
g3
VSTD-Conroy-2010
p46
sg5
S'PMC2956530'
p47
sg7
g35
sg9
V20823124.xml
p48
sa(dp49
g3
VSTD-Dangour-2011
p50
sg5
S'PMC3079648'
p51
sg7
g35
sg9
V21526229.xml
p52
sa(dp53
g3
VSTD-Logan-2010
p54
sg5
S'PMC2868162'
p55
sg7
g35
sg9
V20460331.xml
p56
sa(dp57
g3
VSTD-Nilforoushzadeh-2007
p58
sg5
S'PMC1891315'
p59
sg7
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p60
sg9
V17466071.xml
p61
sa(dp62
g3
VSTD-Papasavvas-2004
p63
sg5
S'PMC539050'
p64
sg7
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p65
sg9
V15630469.xml
p66
sa(dp67
g3
VSTD-Hager-1996
p68
sg5
S'PMC2364471'
p69
sg7
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p70
sg9
V18476075.xml
p71
sa(dp72
g3
VSTD-Catani-2009
p73
sg5
S'PMC2685130'
p74
sg7
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p75
sg9
V19439099.xml
p76
sa(dp77
g3
VSTD-Haran-2010
p78
sg5
S'PMC2876235'
p79
sg7
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p80
sg9
V20501583.xml
p81
sa(dp82
g3
VSTD-Elliott-2005
p83
sg5
S'PMC1352364'
p84
sg7
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p85
sg9
V16371154.xml
p86
sa(dp87
g3
VSTD-Selby-1989
p88
sg5
S'PMC2247066'
p89
sg7
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p90
sg9
V2539180.xml
p91
sa(dp92
g3
VSTD-Anderson-1984
p93
sg5
S'PMC1976928'
p94
sg7
g90
sg9
V6378236.xml
p95
sa(dp96
g3
VSTD-Noyes-1998
p97
sg5
S'PMC1784814'
p98
sg7
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p99
sg9
V9894177.xml
p100
sa(dp101
g3
VSTD-Jamtvedt-2008
p102
sg5
S'PMC2518288'
p103
sg7
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p104
sg9
V18710487.xml
p105
sa(dp106
g3
VSTD-Finsen-2006
p107
sg5
S'PMC1459867'
p108
sg7
g104
sg9
V16646970.xml
p109
sa(dp110
g3
VSTD-Cockayne-2005
p111
sg5
S'PMC1280926'
p112
sg7
g104
sg9
V16250910.xml
p113
sa(dp114
g3
VSTD-Leece-2006a
p115
sg5
S'PMC1550620'
p116
sg7
g104
sg9
V15631963.xml
p117
sa(dp118
g3
VSTD-Roberts-2004
p119
sg5
S'PMC534094'
p120
sg7
g104
sg9
V15533256.xml
p121
sa(dp122
g3
VSTD-McKenzie_x002d_McHarg-2005
p123
sg5
S'PMC1190172'
p124
sg7
g104
sg9
V16091137.xml
p125
sa(dp126
g3
VSTD-Kenyon-2005
p127
sg5
S'PMC1201139'
p128
sg7
g104
sg9
V16109160.xml
p129
sa(dp130
g3
VSTD-Leece-2006b
p131
sg5
S'PMC1550620'
p132
sg7
g104
sg9
V15631963.xml
p133
sa(dp134
g3
VSTD-Br_x00f8_gger-2007
p135
sg5
S'PMC2270416'
p136
sg7
g104
sg9
V18174120.xml
p137
sa(dp138
g3
VSTD-Lavelle-2008
p139
sg5
S'PMC2427026'
p140
sg7
g104
sg9
V18507819.xml
p141
sa(dp142
g3
VSTD-Harrison-2004
p143
sg5
S'PMC534787'
p144
sg7
g104
sg9
V15537429.xml
p145
sa(dp146
g3
VSTD-Moses-2004
p147
sg5
S'PMC449720'
p148
sg7
g104
sg9
V15222889.xml
p149
sa(dp150
g3
VSTD-Clark-TJ-2001
p151
sg5
S'PMC64502'
p152
sg7
g104
sg9
V11782286.xml
p153
sa(dp154
g3
VSTD-Body-2004
p155
sg5
S'PMC2409647'
p156
sg7
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p157
sg9
V15026791.xml
p158
sa(dp159
g3
VSTD-Ziboh-2004
p160
sg5
S'PMC2275406'
p161
sg7
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p162
sg9
V15154607.xml
p163
sa(dp164
g3
VSTD-Fridkin-2002
p165
sg5
S'PMC3369588'
p166
sg7
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p167
sg9
V12095438.xml
p168
sa(dp169
g3
VSTD-Luabeya-2007
p170
sg5
S'PMC1891438'
p171
sg7
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p172
sg9
V17593956.xml
p173
sa(dp174
g3
VSTD-Del-Romero-2010
p175
sg5
S'PMC2871073'
p176
sg7
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p177
sg9
V20472675.xml
p178
sa(dp179
g3
VSTD-McKeith-2000
p180
sg5
S'PMC3739737'
p181
sg7
VCD006504 v. 4.0 Cholinesterase inhibitors for dementia with Lewy bodies Parkinson's disease dementia and cognitive .rm5
p182
sg9
V23951200.xml
p183
sa(dp184
g3
VSTD-McKeith-2000
p185
sg5
S'PMC3739737'
p186
sg7
VCD003672 v. 7.0 Cholinesterase inhibitors for dementia with Lewy bodies.rm5
p187
sg9
V23951200.xml
p188
sa(dp189
g3
VSTD-Yang-2001
p190
sg5
S'PMC3414298'
p191
sg7
VCD008510 v. 3.7 Chinese herbal medicines for threatened miscarriage.rm5
p192
sg9
V22904831.xml
p193
sa(dp194
g3
VSTD-Liu-2008
p195
sg5
S'PMC3629611'
p196
sg7
g192
sg9
V23634098.xml
p197
sa(dp198
g3
VSTD-Djibuti-2009
p199
sg5
S'PMC3226230'
p200
sg7
VCD008145 v. 2.2 Interventions for improving coverage of child immunization in low- and middle-income countries.rm5
p201
sg9
V19828055.xml
p202
sa(dp203
g3
VSTD-Andersson-2009
p204
sg5
S'PMC3226240'
p205
sg7
g201
sg9
V19828066.xml
p206
sa(dp207
g3
VSTD-Tonwe_x002d_Gold-2007
p208
sg5
S'PMC1949842'
p209
sg7
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p210
sg9
V17713983.xml
p211
sa(dp212
g3
VSTD-Domenge-2000
p213
sg5
S'PMC2363468'
p214
sg7
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p215
sg9
V11189100.xml
p216
sa(dp217
g3
VSTD-UKHAN-2010
p218
sg5
S'PMC2806549'
p219
sg7
g215
sg9
V19875337.xml
p220
sa(dp221
g3
VSTD-Lenssen-2008
p222
sg5
S'PMC2386789'
p223
sg7
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p224
sg9
V18442423.xml
p225
sa(dp226
g3
VSTD-Davis-1988
p227
sg5
S'PMC3195724'
p228
sg7
VCD002124 v. 5.0 Herbal and dietary therapies for primary and secondary dysmenorrhoea.rm5
p229
sg9
V21961521.xml
p230
sa(dp231
g3
VSTD-Kerse-2008
p232
sg5
S'PMC2565754'
p233
sg7
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p234
sg9
V18845605.xml
p235
sa(dp236
g3
VSTD-Crotty-2004b
p237
sg5
S'PMC415557'
p238
sg7
g234
sg9
V15066200.xml
p239
sa(dp240
g3
VSTD-Stenvall-2007
p241
sg5
S'PMC1766476'
p242
sg7
g234
sg9
V17061151.xml
p243
sa(dp244
g3
VSTD-Smith-2010
p245
sg5
S'PMC3140031'
p246
sg7
VCD007854 v. 3.0 Acupuncture for dysmenorrhoea.rm5
p247
sg9
V21799683.xml
p248
sa(dp249
g3
VSTD-EPHT-2006
p250
sg5
S'PMC2330032'
p251
sg7
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p252
sg9
V18366766.xml
p253
sa(dp254
g3
VSTD-Lauretti-2003
p255
sg5
S'PMC2376845'
p256
sg7
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p257
sg9
V14647133.xml
p258
sa(dp259
g3
VSTD-Campos-2007
p260
sg5
S'PMC3476141'
p261
sg7
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p262
sg9
V17563840.xml
p263
sa(dp264
g3
VSTD-Aubin-2008
p265
sg5
S'PMC2569194'
p266
sg7
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p267
sg9
V18263663.xml
p268
sa(dp269
g3
VSTD-Rennard-2011
p270
sg5
S'PMC3281242'
p271
sg7
g267
sg9
V22080588.xml
p272
sa(dp273
g3
VSTD-Avasthi-2001
p274
sg5
S'PMC2956152'
p275
sg7
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p276
sg9
V21407865.xml
p277
sa(dp278
g3
VSTD-King-1999
p279
sg5
S'PMC2722588'
p280
sg7
VCD001027 v. 14.0 Cognitive behaviour therapy for chronic fatigue syndrome in adults.rm5
p281
sg9
V19594903.xml
p282
sa(dp283
g3
VSTD-Becker-2010
p284
sg5
S'PMC2888216'
p285
sg7
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p286
sg9
V20370912.xml
p287
sa(dp288
g3
VSTD-Curtis-2007
p289
sg5
S'PMC1950500'
p290
sg7
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p291
sg9
V17640375.xml
p292
sa(dp293
g3
VSTD-Elserafy-2009
p294
sg5
S'PMC2813645'
p295
sg7
g291
sg9
V19448377.xml
p296
sa(dp297
g3
VSTD-Schilling-2008
p298
sg5
S'PMC2957327'
p299
sg7
VCD002817 v. 10.2 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
p300
sg9
V20976096.xml
p301
sa(dp302
g3
VSTD-de-Bruin-2010a
p303
sg5
S'PMC2957229'
p304
sg7
g300
sg9
V20976086.xml
p305
sa(dp306
g3
VSTD-de-Bruin-2010b
p307
sg5
S'PMC2957229'
p308
sg7
g300
sg9
V20976086.xml
p309
sa(dp310
g3
VSTD-Dobbins-2009
p311
sg5
S'PMC2936828'
p312
sg7
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p313
sg9
V19775439.xml
p314
sa(dp315
g3
VSTD-Francis-2008
p316
sg5
S'PMC3749169'
p317
sg7
VCD006170 v. 4.2 Methods of milk expression for lactating women.rm5
p318
sg9
V23991112.xml
p319
sa(dp320
g3
VSTD-Itoh-2010
p321
sg5
S'PMC2852376'
p322
sg7
VCD007070 v. 3.5 Acupuncture for treating fibromyalgia.rm5
p323
sg9
V20331844.xml
p324
sa(dp325
g3
VSTD-Naik-2010
p326
sg5
S'PMC3169962'
p327
sg7
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p328
sg9
V21935312.xml
p329
sa(dp330
g3
VSTD-Rutten_x002d_van-Molken-2007
p331
sg5
S'PMC1913175'
p332
sg7
g328
sg9
V17370096.xml
p333
sa(dp334
g3
VSTD-Ethgen-2009
p335
sg5
S'PMC2679061'
p336
sg7
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p337
sg9
V19358717.xml
p338
sa(dp339
g3
VSTD-Yu-2010
p340
sg5
S'PMC2886040'
p341
sg7
g337
sg9
V20482769.xml
p342
sa(dp343
g3
VSTD-Hopewell-2010
p344
sg5
S'PMC2844941'
p345
sg7
g337
sg9
V20332510.xml
p346
sa(dp347
g3
VSTD-Partsinevelou-2009
p348
sg5
S'PMC2788535'
p349
sg7
g337
sg9
V19930576.xml
p350
sa(dp351
g3
VSTD-Prady-2008
p352
sg5
S'PMC2216683'
p353
sg7
g337
sg9
V18270568.xml
p354
sa(dp355
g3
VSTD-Montan_x00e9_-2010
p356
sg5
S'PMC2822812'
p357
sg7
g337
sg9
V20067642.xml
p358
sa(dp359
g3
VSTD-Senkus_x002d_Konefka-2005
p360
sg5
S'PMC2361948'
p361
sg7
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p362
sg9
V15770205.xml
p363
sa(dp364
g3
VSTD-MRC-1991
p365
sg5
S'PMC1971762'
p366
sg7
g362
sg9
V1705140.xml
p367
sa(dp368
g3
VSTD-MRC-1992
p369
sg5
S'PMC1977779'
p370
sg7
g362
sg9
V1377484.xml
p371
sa(dp372
g3
VSTD-Frankel-2010
p373
sg5
S'PMC2890979'
p374
sg7
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p375
sg9
V20058059.xml
p376
sa(dp377
g3
VSTD-Brown-2001
p378
sg5
S'PMC2375236'
p379
sg7
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p380
sg9
V11720460.xml
p381
sa(dp382
g3
VSTD-Rosen-2006
p383
sg5
S'PMC3734469'
p384
sg7
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p385
sg9
V23863613.xml
p386
sa(dp387
g3
VSTD-Lumley-2006
p388
sg5
S'PMC305350'
p389
sg7
g385
sg9
V14629776.xml
p390
sa(dp391
g3
VSTD-Florence-2011
p392
sg5
S'PMC3116927'
p393
sg7
g385
sg9
V21680632.xml
p394
sa(dp395
g3
VSTD-ENGAGE-2009
p396
sg5
S'PMC2777786'
p397
sg7
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p398
sg9
V19684043.xml
p399
sa(dp400
g3
VSTD-Pavesi-1993
p401
sg5
S'PMC3640956'
p402
sg7
VCD003993 v. 4.0 Thymic peptides for treatment of cancer patients.rm5
p403
sg9
V23618554.xml
p404
sa(dp405
g3
VSTD-Howden_x002d_Chapman-2008
p406
sg5
S'PMC2658826'
p407
sg7
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p408
sg9
V18812366.xml
p409
sa(dp410
g3
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p411
sg5
S'PMC2638601'
p412
sg7
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p413
sg9
V18979150.xml
p414
sa(dp415
g3
VSTD-Driver-2011-age-matched
p416
sg5
S'PMC3023971'
p417
sg7
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p418
sg9
V21252104.xml
p419
sa(dp420
g3
VSTD-Driver-2011-age_x002b_-matched
p421
sg5
S'PMC3023971'
p422
sg7
g418
sg9
V21252104.xml
p423
sa(dp424
g3
VSTD-Yin-2005
p425
sg5
S'PMC3523975'
p426
sg7
VCD002900 v. 6.0 Surgical methods for first trimester termination of pregnancy.rm5
p427
sg9
V23040108.xml
p428
sa(dp429
g3
VSTD-Burton-2006
p430
sg5
S'PMC3216418'
p431
sg7
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p432
sg9
V16508640.xml
p433
sa(dp434
g3
VSTD-Rafati-2011
p435
sg5
S'PMC3232099'
p436
sg7
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p437
sg9
V22615652.xml
p438
sa(dp439
g3
VSTD-Rachow-2011
p440
sg5
S'PMC3126807'
p441
sg7
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p442
sg9
V21738575.xml
p443
sa(dp444
g3
VSTD-Scott-2011
p445
sg5
S'PMC3144192'
p446
sg7
g442
sg9
V21814495.xml
p447
sa(dp448
g3
VSTD-Boehme-2011f
p449
sg5
S'PMC3085933'
p450
sg7
g442
sg9
V21507477.xml
p451
sa(dp452
g3
VSTD-Boehme-2011e
p453
sg5
S'PMC3085933'
p454
sg7
g442
sg9
V21507477.xml
p455
sa(dp456
g3
VSTD-Boehme-2011d
p457
sg5
S'PMC3085933'
p458
sg7
g442
sg9
V21507477.xml
p459
sa(dp460
g3
VSTD-Boehme-2011c
p461
sg5
S'PMC3085933'
p462
sg7
g442
sg9
V21507477.xml
p463
sa(dp464
g3
VSTD-Boehme-2011b
p465
sg5
S'PMC3085933'
p466
sg7
g442
sg9
V21507477.xml
p467
sa(dp468
g3
VSTD-Boehme-2011a
p469
sg5
S'PMC3085933'
p470
sg7
g442
sg9
V21507477.xml
p471
sa(dp472
g3
VSTD-Lawn-2011
p473
sg5
S'PMC3144215'
p474
sg7
g442
sg9
V21818180.xml
p475
sa(dp476
g3
VSTD-Barth-2005
p477
sg5
S'PMC2736492'
p478
sg7
VCD008012 v. 3.0 Psychological and pharmacological interventions for depression in patients with coronary artery dise.rm5
p479
sg9
V19742062.xml
p480
sa(dp481
g3
VSTD-Pakasi-2010
p482
sg5
S'PMC2957385'
p483
sg7
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p484
sg9
V20920186.xml
p485
sa(dp486
g3
VSTD-Martins-2009
p487
sg5
S'PMC2767482'
p488
sg7
g484
sg9
V19858174.xml
p489
sa(dp490
g3
VSTD-Johansson-2008
p491
sg5
S'PMC2607225'
p492
sg7
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p493
sg9
V19018255.xml
p494
sa(dp495
g3
VSTD-Ghorbani-2009
p496
sg5
S'PMC2847809'
p497
sg7
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p498
sg9
V20368925.xml
p499
sa(dp500
g3
VSTD-Eriksen-1997
p501
sg5
S'PMC2364551'
p502
sg7
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p503
sg9
V18476153.xml
p504
sa(dp505
g3
VSTD-Katsourakis-2010
p506
sg5
S'PMC3108665'
p507
sg7
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p508
sg9
V21694864.xml
p509
sa(dp510
g3
VSTD-Cornuz-2008
p511
sg5
S'PMC2432028'
p512
sg7
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p513
sg9
V18575629.xml
p514
sa(dp515
g3
VSTD-Yu-1995
p516
sg5
S'PMC3616209'
p517
sg7
VCD003183 v. 6.0 Medicinal herbs for hepatitis C virus infection.rm5
p518
sg9
V23573108.xml
p519
sa(dp520
g3
VSTD-He-2008
p521
sg5
S'PMC3142497'
p522
sg7
VCD008960 v. 2.0 Phyllanthus species for chronic hepatitis B virus infection.rm5
p523
sg9
V21672207.xml
p524
sa(dp525
g3
VSTD-Kawata-1994
p526
sg5
S'PMC2363838'
p527
sg7
VCD003181 v. 6.0 Bile acids for viral hepatitis.rm5
p528
sg9
V11286466.xml
p529
sa(dp530
g3
VSTD-Ricca-2007
p531
sg5
S'PMC3015793'
p532
sg7
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p533
sg9
V17663093.xml
p534
sa(dp535
g3
VSTD-Ataoglu-2003
p536
sg5
S'PMC3055095'
p537
sg7
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p538
sg9
V12923337.xml
p539
sa(dp540
g3
VSTD-Ettinger-2009
p541
sg5
S'PMC2627861'
p542
sg7
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p543
sg9
V19165383.xml
p544
sa(dp545
g3
VSTD-Freeman-2010
p546
sg5
S'PMC3651198'
p547
sg7
VCD001396 v. 7.3 Selective serotonin reuptake inhibitors for premenstrual syndrome.rm5
p548
sg9
V23675477.xml
p549
sa(dp550
g3
VSTD-Yeboah_x002d_Antwi-2010
p551
sg5
S'PMC2943441'
p552
sg7
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p553
sg9
V20877714.xml
p554
sa(dp555
g3
VSTD-Kouyate-2008
p556
sg5
S'PMC2287184'
p557
sg7
g553
sg9
V18364043.xml
p558
sa(dp559
g3
VSTD-Mubi-2011
p560
sg5
S'PMC3130036'
p561
sg7
g553
sg9
V21750697.xml
p562
sa(dp563
g3
VSTD-Kangwana-2011
p564
sg5
S'PMC3104978'
p565
sg7
g553
sg9
V21655317.xml
p566
sa(dp567
g3
VSTD-Akhter-2009
p568
sg5
S'PMC2695684'
p569
sg7
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p570
sg9
V19417743.xml
p571
sa(dp572
g3
VSTD-Trevisan-2008
p573
sg5
S'PMC2447590'
p574
sg7
VCD004127 v. 7.0 Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respirator.rm5
p575
sg9
V18439326.xml
p576
sa(dp577
g3
VSTD-Channabasavanna-1987
p578
sg5
S'PMC3172444'
p579
sg7
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p580
sg9
V21927264.xml
p581
sa(dp582
g3
VSTD-Thornton-2006
p583
sg5
S'PMC3564866'
p584
sg7
VCD008137 v. 1.0 The impact of conditional cash transfers on health outcomes and use of health services in low and mi.rm5
p585
sg9
V23393551.xml
p586
sa(dp587
g3
VSTD-Atapour-2006
p588
sg5
S'PMC3748638'
p589
sg7
VCD006894 v. 4.0 Interventions for preventing infectious complications in haemodialysis patients with central venous .rm5
p590
sg9
V23977660.xml
p591
sa(dp592
g3
VSTD-Beck-2007
p593
sg5
S'PMC1896161'
p594
sg7
VCD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
p595
sg9
V17543129.xml
p596
sa(dp597
g3
VSTD-Smith-2010
p598
sg5
S'PMC2965151'
p599
sg7
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p600
sg9
V20978060.xml
p601
sa(dp602
g3
VSTD-Steckelberg-2011
p603
sg5
S'PMC3106362'
p604
sg7
g600
sg9
V21636633.xml
p605
sa(dp606
g3
VSTD-Vadillo_x002d_Ortega-2011
p607
sg5
S'PMC3100912'
p608
sg7
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p609
sg9
V21596735.xml
p610
sa(dp611
g3
VSTD-Zeng-2008
p612
sg5
S'PMC2577799'
p613
sg7
g609
sg9
V18996930.xml
p614
sa(dp615
g3
VSTD-Fry-2003
p616
sg5
S'PMC2376929'
p617
sg7
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p618
sg9
V12915873.xml
p619
sa(dp620
g3
VSTD-Young-2006
p621
sg5
S'PMC2360713'
p622
sg7
g618
sg9
V17047645.xml
p623
sa(dp624
g3
VSTD-Osman-2008
p625
sg5
S'PMC2922723'
p626
sg7
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p627
sg9
V19703826.xml
p628
sa(dp629
g3
VSTD-Ataoglu-2003
p630
sg5
S'PMC3055095'
p631
sg7
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p632
sg9
V12923337.xml
p633
sa(dp634
g3
VSTD-Priotto-2006
p635
sg5
S'PMC1687208'
p636
sg7
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p637
sg9
V17160135.xml
p638
sa(dp639
g3
VSTD-Benn-2010
p640
sg5
S'PMC2835853'
p641
sg7
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p642
sg9
V20215360.xml
p643
sa(dp644
g3
VSTD-Auerbach-2002a
p645
sg5
S'PMC3507824'
p646
sg7
VCD005321 v. 3.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
p647
sg9
V23209545.xml
p648
sa(dp649
g3
VSTD-Sinclair-2007
p650
sg5
S'PMC3471286'
p651
sg7
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p652
sg9
V22733107.xml
p653
sa(dp654
g3
VSTD-Hoddinott-2009
p655
sg5
S'PMC2635594'
p656
sg7
g652
sg9
V19181729.xml
p657
sa(dp658
g3
VSTD-Corbett-2006
p659
sg5
S'PMC1483908'
p660
sg7
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p661
sg9
V16796402.xml
p662
sa(dp663
g3
VSTD-Coskun-2011
p664
sg5
S'PMC3109380'
p665
sg7
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p666
sg9
V21789385.xml
p667
sa(dp668
g3
VSTD-Beran-2009a
p669
sg5
S'PMC2639595'
p670
sg7
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p671
sg9
V19149900.xml
p672
sa(dp673
g3
VSTD-Varkey-2011
p674
sg5
S'PMC3236524'
p675
sg7
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p676
sg9
V21890526.xml
p677
sa(dp678
g3
VSTD-Bahadoran-2010
p679
sg5
S'PMC3208940'
p680
sg7
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p681
sg9
V22069407.xml
p682
sa(dp683
g3
VSTD-Riley-2005
p684
sg5
S'PMC3479413'
p685
sg7
VCD008033 v. 3.2 Reduction versus abrupt cessation in smokers who want to quit.rm5
p686
sg9
V22852768.xml
p687
sa(dp688
g3
VSTD-Bertleff-2009
p689
sg5
S'PMC2691927'
p690
sg7
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p691
sg9
V19430829.xml
p692
sa(dp693
g3
VSTD-Chen-2009
p694
sg5
S'PMC2666722'
p695
sg7
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p696
sg9
V19284644.xml
p697
sa(dp698
g3
VSTD-Cowling-2008
p699
sg5
S'PMC2364646'
p700
sg7
g696
sg9
V18461182.xml
p701
sa(dp702
g3
VSTD-Wu-2004
p703
sg5
S'PMC3322931'
p704
sg7
g696
sg9
V15030685.xml
p705
sa(dp706
g3
VSTD-MacIntyre-2009
p707
sg5
S'PMC2662657'
p708
sg7
g696
sg9
V19193267.xml
p709
sa(dp710
g3
VSTD-Lau-2004a
p711
sg5
S'PMC3323085'
p712
sg7
g696
sg9
V15200846.xml
p713
sa(dp714
g3
VSTD-Cowling-2010
p715
sg5
S'PMC3152767'
p716
sg7
g696
sg9
V20353566.xml
p717
sa(dp718
g3
VSTD-Psaradellis-2010
p719
sg5
S'PMC3278944'
p720
sg7
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p721
sg9
V22371721.xml
p722
sa(dp723
g3
VSTD-Atzpodien-2002
p724
sg5
S'PMC2375173'
p725
sg7
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p726
sg9
V11870502.xml
p727
sa(dp728
g3
VSTD-Johnston-1998
p729
sg5
S'PMC2150174'
p730
sg7
g726
sg9
V9579834.xml
p731
sa(dp732
g3
VSTD-Kristjansson-1999
p733
sg5
S'PMC3402187'
p734
sg7
VCD003195 v. 6.4 Urodynamic studies for management of urinary incontinence in children and adults.rm5
p735
sg9
V22833787.xml
p736
sa(dp737
g3
VSTD-Shepherd-1998
p738
sg5
S'PMC2063048'
p739
sg7
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p740
sg9
V9744511.xml
p741
sa(dp742
g3
VSTD-Lin-2005
p743
sg5
S'PMC1550679'
p744
sg7
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p745
sg9
V16236699.xml
p746
sa(dp747
g3
VSTD-Ross-2004
p748
sg5
S'PMC1550594'
p749
sg7
g745
sg9
V15249261.xml
p750
sa(dp751
g3
VSTD-Gentile-2009
p752
sg5
S'PMC2758893'
p753
sg7
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p754
sg9
V19765270.xml
p755
sa(dp756
g3
VSTD-Lazaar-2007
p757
sg5
S'PMC2040215'
p758
sg7
g754
sg9
V17718785.xml
p759
sa(dp760
g3
VSTD-Rosenberg-2007
p761
sg5
S'PMC1964758'
p762
sg7
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p763
sg9
V17683577.xml
p764
sa(dp765
g3
VSTD-Crotty-2004
p766
sg5
S'PMC415557'
p767
sg7
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p768
sg9
V15066200.xml
p769
sa(dp770
g3
VSTD-Fretheim-2006
p771
sg5
S'PMC1472698'
p772
sg7
g768
sg9
V16737349.xml
p773
sa(dp774
g3
VSTD-Schultz-2004
p775
sg5
S'PMC394324'
p776
sg7
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p777
sg9
V15113451.xml
p778
sa(dp779
g3
VSTD-Callaway-2010
p780
sg5
S'PMC2890340'
p781
sg7
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p782
sg9
V20357374.xml
p783
sa(dp784
g3
VSTD-Bijker-2000b
p785
sg5
S'PMC2364244'
p786
sg7
VMR000009 v. 8.2 Outcomes of patients who participate in randomized controlled trials compared to similar patients re.rm5
p787
sg9
V12237770.xml
p788
sa(dp789
g3
VSTD-Bijker-2000a
p790
sg5
S'PMC2364244'
p791
sg7
g787
sg9
V12237770.xml
p792
sa(dp793
g3
VSTD-Callaway-2010
p794
sg5
S'PMC2890340'
p795
sg7
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p796
sg9
V20357374.xml
p797
sa(dp798
g3
VSTD-Korpi_x002d_Hyovalti-2011
p799
sg5
S'PMC3078095'
p800
sg7
g796
sg9
V21429234.xml
p801
sa(dp802
g3
VSTD-Moses-2009
p803
sg5
S'PMC2681032'
p804
sg7
g796
sg9
V19279301.xml
p805
sa(dp806
g3
VSTD-Luoto-2011
p807
sg5
S'PMC3096610'
p808
sg7
g796
sg9
V21610860.xml
p809
sa(dp810
g3
VSTD-Ott-1998
p811
sg5
S'PMC3015252'
p812
sg7
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p813
sg9
V10036122.xml
p814
sa(dp815
g3
VSTD-Scott-2002
p816
sg5
S'PMC1784606'
p817
sg7
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p818
sg9
V12530483.xml
p819
sa(dp820
g3
VSTD-Boogaerts-2003
p821
sg5
S'PMC2376376'
p822
sg7
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p823
sg9
V12671693.xml
p824
sa(dp825
g3
VSTD-Wilkinson-2006
p826
sg5
S'PMC2361228'
p827
sg7
g823
sg9
V16570051.xml
p828
sa(dp829
g3
VSTD-Lemmens-2007
p830
sg5
S'PMC2944304'
p831
sg7
VCD007362 v. 2.11 Sugammadex a selective reversal medication for preventing postoperative residual neuromuscular bloc.rm5
p832
sg9
V20809967.xml
p833
sa(dp834
g3
VSTD-Harrison-1996
p835
sg5
S'PMC3340390'
p836
sg7
VCD007355 v. 6.0 Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.rm5
p837
sg9
V22558179.xml
p838
sa(dp839
g3
VSTD-Benn-2010
p840
sg5
S'PMC2835853'
p841
sg7
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p842
sg9
V20215360.xml
p843
sa(dp844
g3
VSTD-MacKie-Child-1990
p845
sg5
S'PMC3417576'
p846
sg7
VCD004416 v. 6.0 Oral evening primrose oil and borage oil for eczema.rm5
p847
sg9
V22905031.xml
p848
sa(dp849
g3
VSTD-MacKie-Adult-1990
p850
sg5
S'PMC3417576'
p851
sg7
g847
sg9
V22905031.xml
p852
sa(dp853
g3
VSTD-Moorthy-2004b
p854
sg5
S'PMC524376'
p855
sg7
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p856
sg9
V15526058.xml
p857
sa(dp858
g3
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p859
sg5
S'PMC2575601'
p860
sg7
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p861
sg9
V18759980.xml
p862
sa(dp863
g3
VSTD-Ko-2009
p864
sg5
S'PMC2650992'
p865
sg7
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p866
sg9
V19270819.xml
p867
sa(dp868
g3
VSTD-Meyer-2008
p869
sg5
S'PMC2253708'
p870
sg7
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p871
sg9
V17995993.xml
p872
sa(dp873
g3
VSTD-Young-2008
p874
sg5
S'PMC2268921'
p875
sg7
g871
sg9
V18304363.xml
p876
sa(dp877
g3
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p878
sg5
S'PMC2291568'
p879
sg7
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p880
sg9
V18414647.xml
p881
sa(dp882
g3
VSTD-Kirwan-2010
p883
sg5
S'PMC3161357'
p884
sg7
g880
sg9
V20858280.xml
p885
sa(dp886
g3
VSTD-Narvekar-2010
p887
sg5
S'PMC2890904'
p888
sg7
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p889
sg9
V20607003.xml
p890
sa(dp891
g3
VSTD-_x005e_Horst-2005
p892
sg5
S'PMC2424122'
p893
sg7
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p894
sg9
V18568115.xml
p895
sa(dp896
g3
VSTD-_x002a_Williams-2012
p897
sg5
S'PMC2955947'
p898
sg7
g894
sg9
V21407853.xml
p899
sa(dp900
g3
VSTD-Ziegler-2010
p901
sg5
S'PMC2845038'
p902
sg7
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p903
sg9
V20067958.xml
p904
sa(dp905
g3
VSTD-Qu-2007
p906
sg5
S'PMC1810361'
p907
sg7
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p908
sg9
V17342250.xml
p909
sa(dp910
g3
VSTD-Bouzari-2011
p911
sg5
S'PMC3217057'
p912
sg7
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p913
sg9
V22026956.xml
p914
sa(dp915
g3
VSTD-Yekta-2011
p916
sg5
S'PMC3233526'
p917
sg7
g913
sg9
V22162919.xml
p918
sa(dp919
g3
VSTD-Egan-1983
p920
sg5
S'PMC3582081'
p921
sg7
VCD005463 v. 3.2 Individual and group-based parenting programmes for the treatment of physical child abuse and neglec.rm5
p922
sg9
V23476865.xml
p923
sa(dp924
g3
VSTD-Starobin-2007
p925
sg5
S'PMC1892551'
p926
sg7
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p927
sg9
V17547746.xml
p928
sa(dp929
g3
VSTD-Tan-2008
p930
sg5
S'PMC2780654'
p931
sg7
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p932
sg9
V18545884.xml
p933
sa(dp934
g3
VSTD-Wamalwa-2009
p935
sg5
S'PMC2708138'
p936
sg7
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p937
sg9
V19549342.xml
p938
sa(dp939
g3
VSTD-Patel-2009
p940
sg5
S'PMC2684117'
p941
sg7
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p942
sg9
V19416499.xml
p943
sa(dp944
g3
VSTD-Patel-2009a-_x0028_zinc_x0029_
p945
sg5
S'PMC2684117'
p946
sg7
g942
sg9
V19416499.xml
p947
sa(dp948
g3
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p949
sg5
S'PMC2684117'
p950
sg7
g942
sg9
V19416499.xml
p951
sa(dp952
g3
VSTD-d-SGCTG-1986
p953
sg5
S'PMC1977737'
p954
sg7
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p955
sg9
V1739629.xml
p956
sa(dp957
g3
VSTD-Meyer-2008
p958
sg5
S'PMC2253708'
p959
sg7
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p960
sg9
V17995993.xml
p961
sa(dp962
g3
VSTD-Unrod-2007
p963
sg5
S'PMC1829425'
p964
sg7
g960
sg9
V17372796.xml
p965
sa(dp966
g3
VSTD-Lalit-2004
p967
sg5
S'PMC2950952'
p968
sg7
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p969
sg9
V21206792.xml
p970
sa(dp971
g3
VSTD-Windbichler-2000
p972
sg5
S'PMC2363351'
p973
sg7
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p974
sg9
V10735496.xml
p975
sa(dp976
g3
VSTD-Hall-2004
p977
sg5
S'PMC2364769'
p978
sg7
g974
sg9
V15305182.xml
p979
sa(dp980
g3
VSTD-Kalilani-2007
p981
sg5
S'PMC2048661'
p982
sg7
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p983
sg9
V18000538.xml
p984
sa(dp985
g3
VSTD-Coulibaly-2006
p986
sg5
S'PMC1533839'
p987
sg7
g983
sg9
V16776817.xml
p988
sa(dp989
g3
VSTD-Kasper-2006
p990
sg5
S'PMC1538611'
p991
sg7
VCD000448 v. 10.0 St John's wort for major depression.rm5
p992
sg9
V16796730.xml
p993
sa(dp994
g3
VSTD-Van-Den-Brenk-1968
p995
sg5
S'PMC2009013'
p996
sg7
VCD005007 v. 5.3 Hyperbaric oxygenation for tumour sensitisation to radiotherapy.rm5
p997
sg9
V4854060.xml
p998
sa(dp999
g3
VSTD-Carter
p1000
sg5
S'PMC3662830'
p1001
sg7
VCD001841 v. 7.0 First-line drugs for hypertension.rm5
p1002
sg9
V23704171.xml
p1003
sa(dp1004
g3
VSTD-Crowther-1986
p1005
sg5
S'PMC3655914'
p1006
sg7
VCD003514 v. 7.0 Bed rest with or without hospitalisation for hypertension during pregnancy.rm5
p1007
sg9
V23642125.xml
p1008
sa(dp1009
g3
VSTD-Horn-2007
p1010
sg5
S'PMC1832131'
p1011
sg7
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p1012
sg9
V17173716.xml
p1013
sa(dp1014
g3
VSTD-McKay-2009
p1015
sg5
S'PMC2817867'
p1016
sg7
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p1017
sg9
V20148084.xml
p1018
sa(dp1019
g3
VSTD-Kim-2011
p1020
sg5
S'PMC3204557'
p1021
sg7
g1017
sg9
V22066097.xml
p1022
sa(dp1023
g3
VSTD-Gajdos-2010
p1024
sg5
S'PMC2946956'
p1025
sg7
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p1026
sg9
V20927359.xml
p1027
sa(dp1028
g3
VSTD-Zeng-2008-_x0028_C_x0029_
p1029
sg5
S'PMC2577799'
p1030
sg7
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p1031
sg9
V18996930.xml
p1032
sa(dp1033
g3
VSTD-Humphrey-2006
p1034
sg5
S'PMC3007097'
p1035
sg7
VCD003648 v. 8.0 Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.rm5
p1036
sg9
V21177735.xml
p1037
sa(dp1038
g3
VSTD-Faglia-2010
p1039
sg5
S'PMC2890332'
p1040
sg7
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p1041
sg9
V20357377.xml
p1042
sa(dp1043
g3
VSTD-Hewlett-1999
p1044
sg5
S'PMC3086034'
p1045
sg7
VCD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
p1046
sg9
V21540202.xml
p1047
sa(dp1048
g3
VSTD-MRC-LU11
p1049
sg5
S'PMC2074683'
p1050
sg7
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p1051
sg9
V8761382.xml
p1052
sa(dp1053
g3
VSTD-Faithfull-2001
p1054
sg5
S'PMC2364007'
p1055
sg7
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p1056
sg9
V11747326.xml
p1057
sa(dp1058
g3
VSTD-de-Vries-2007a
p1059
sg5
S'PMC1913177'
p1060
sg7
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p1061
sg9
V17372669.xml
p1062
sa(dp1063
g3
VSTD-Makvandi-2010
p1064
sg5
S'PMC3081214'
p1065
sg7
VCD009243 v. 3.0 Antispasmodics for labour.rm5
p1066
sg9
V21495198.xml
p1067
sa(dp1068
g3
VSTD-Horita-2007
p1069
sg5
S'PMC2409178'
p1070
sg7
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p1071
sg9
V17497466.xml
p1072
sa(dp1073
g3
VSTD-Soltanian-2010
p1074
sg5
S'PMC3302710'
p1075
sg7
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p1076
sg9
V22427772.xml
p1077
sa(dp1078
g3
VSTD-Wang-2012
p1079
sg5
S'PMC3292236'
p1080
sg7
g1076
sg9
V22454655.xml
p1081
sa(dp1082
g3
VSTD-Castro-2008
p1083
sg5
S'PMC2664121'
p1084
sg7
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p1085
sg9
V18719756.xml
p1086
sa(dp1087
g3
VSTD-Pras-1995
p1088
sg5
S'PMC3399783'
p1089
sg7
VCD008285 v. 2.0 Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer individual patien.rm5
p1090
sg9
V22815624.xml
p1091
sa(dp1092
g3
VSTD-Michaud-2005
p1093
sg5
S'PMC2361644'
p1094
sg7
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p1095
sg9
V16175184.xml
p1096
sa(dp1097
g3
VSTD-ba-Kissling-2011
p1098
sg5
S'PMC3216983'
p1099
sg7
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p1100
sg9
V22110695.xml
p1101
sa(dp1102
g3
VSTD-ba-Valenciano-2011
p1103
sg5
S'PMC3019108'
p1104
sg7
g1100
sg9
V21379316.xml
p1105
sa(dp1106
g3
VSTD-ab-Mallory-2010
p1107
sg5
S'PMC2966412'
p1108
sg7
g1100
sg9
V21060780.xml
p1109
sa(dp1110
g3
VSTD-Song-2006
p1111
sg5
S'PMC2721929'
p1112
sg7
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p1113
sg9
V17179687.xml
p1114
sa(dp1115
g3
VSTD-Chancellor-2008
p1116
sg5
S'PMC2325270'
p1117
sg7
g1113
sg9
V18324952.xml
p1118
sa(dp1119
g3
VSTD-Bautmans-2005
p1120
sg5
S'PMC1368976'
p1121
sg7
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p1122
sg9
V16372905.xml
p1123
sa(dp1124
g3
VSTD-Kerse-2008
p1125
sg5
S'PMC2565754'
p1126
sg7
g1122
sg9
V18845605.xml
p1127
sa(dp1128
g3
VSTD-Sackley-2009
p1129
sg5
S'PMC2736373'
p1130
sg7
g1122
sg9
V19723707.xml
p1131
sa(dp1132
g3
VSTD-Chin-A-Paw-2004
p1133
sg5
S'PMC471553'
p1134
sg7
g1122
sg9
V15233841.xml
p1135
sa(dp1136
g3
VSTD-Study-315
p1137
sg5
S'PMC2962290'
p1138
sg7
VCD001190 v. 14.0 Donepezil for dementia due to Alzheimer's disease.rm5
p1139
sg9
V21455360.xml
p1140
sa(dp1141
g3
VSTD-Gebbia-1996
p1142
sg5
S'PMC2074540'
p1143
sg7
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p1144
sg9
V8664133.xml
p1145
sa(dp1146
g3
VSTD-Subrahmanyam-1996a
p1147
sg5
S'PMC2991644'
p1148
sg7
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p1149
sg9
V21189872.xml
p1150
sa(dp1151
g3
VSTD-Subrahmanyam-1996c
p1152
sg5
S'PMC2894501'
p1153
sg7
g1149
sg9
V20640210.xml
p1154
sa(dp1155
g3
VSTD-Nilforoushzadeh-2007
p1156
sg5
S'PMC1891315'
p1157
sg7
g1149
sg9
V17466071.xml
p1158
sa(dp1159
g3
VSTD-Baghel-2009
p1160
sg5
S'PMC2845359'
p1161
sg7
g1149
sg9
V20368852.xml
p1162
sa(dp1163
g3
VSTD-Subrahmanyam-1993b
p1164
sg5
S'PMC2894501'
p1165
sg7
g1149
sg9
V20640210.xml
p1166
sa(dp1167
g3
VSTD-a01-MRC-LU02
p1168
sg5
S'PMC1977284'
p1169
sg7
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p1170
sg9
V3907687.xml
p1171
sa(dp1172
g3
VSTD-d04-RLW-8351
p1173
sg5
S'PMC1971367'
p1174
sg7
g1170
sg9
V1691921.xml
p1175
sa(dp1176
g3
VSTD-d06-Southampton
p1177
sg5
S'PMC1971367'
p1178
sg7
g1170
sg9
V1691921.xml
p1179
sa(dp1180
g3
VSTD-Madhusudan-2004
p1181
sg5
S'PMC2394342'
p1182
sg7
VCD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
p1183
sg9
V14562010.xml
p1184
sa(dp1185
g3
VSTD-Li-2003
p1186
sg5
S'PMC3707322'
p1187
sg7
VCD006625 v. 3.0 Quetiapine versus other atypical antipsychotics for schizophrenia.rm5
p1188
sg9
V23869281.xml
p1189
sa(dp1190
g3
VSTD-Rosenfeldt-2011
p1191
sg5
S'PMC3063826'
p1192
sg7
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p1193
sg9
V21385466.xml
p1194
sa(dp1195
g3
VSTD-Kylmala-1997
p1196
sg5
S'PMC2228066'
p1197
sg7
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p1198
sg9
V9328156.xml
p1199
sa(dp1200
g3
VSTD-Morice-2007
p1201
sg5
S'PMC2228375'
p1202
sg7
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p1203
sg9
V17887990.xml
p1204
sa(dp1205
g3
VSTD-Solomon-2007a
p1206
sg5
S'PMC1824772'
p1207
sg7
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p1208
sg9
V17356969.xml
p1209
sa(dp1210
g3
VSTD-Lafata-2007
p1211
sg5
S'PMC1824751'
p1212
sg7
g1208
sg9
V17356966.xml
p1213
sa(dp1214
g3
VSTD-Pavord-2007
p1215
sg5
S'PMC2174463'
p1216
sg7
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p1217
sg9
V17897478.xml
p1218
sa(dp1219
g3
VSTD-Pras-2000
p1220
sg5
S'PMC3399783'
p1221
sg7
VCD002225 v. 7.0 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.rm5
p1222
sg9
V22815624.xml
p1223
sa(dp1224
g3
VSTD-Todd-1997
p1225
sg5
S'PMC3055815'
p1226
sg7
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p1227
sg9
V21324139.xml
p1228
sa(dp1229
g3
VSTD-Timmer-2002
p1230
sg5
S'PMC115863'
p1231
sg7
g1227
sg9
V11978183.xml
p1232
sa(dp1233
g3
VSTD-Chel-2008
p1234
sg5
S'PMC2277446'
p1235
sg7
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p1236
sg9
V17874029.xml
p1237
sa(dp1238
g3
VSTD-Ito-2010
p1239
sg5
S'PMC2972638'
p1240
sg7
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p1241
sg9
V20049950.xml
p1242
sa(dp1243
g3
VSTD-Kruis-2009
p1244
sg5
S'PMC3269751'
p1245
sg7
g1241
sg9
V18832520.xml
p1246
sa(dp1247
g3
VSTD-Khorana-1972
p1248
sg5
S'PMC3013192'
p1249
sg7
VCD002117 v. 7.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
p1250
sg9
V22058522.xml
p1251
sa(dp1252
g3
VSTD-Battacharya-2008
p1253
sg5
S'PMC2505091'
p1254
sg7
VCD000057 v. 7.0 Clomiphene citrate for unexplained subfertility in women.rm5
p1255
sg9
V18687718.xml
p1256
sa(dp1257
g3
VSTD-Cao-2009
p1258
sg5
S'PMC2726958'
p1259
sg7
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p1260
sg9
V19508995.xml
p1261
sa(dp1262
g3
VSTD-Cuervo-2006
p1263
sg5
S'PMC1468428'
p1264
sg7
VCD000330 v. 12.0 Enemas during labour.rm5
p1265
sg9
V16545140.xml
p1266
sa(dp1267
g3
VSTD-Bahwere-2008
p1268
sg5
S'PMC2536666'
p1269
sg7
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p1270
sg9
V18671876.xml
p1271
sa(dp1272
g3
VSTD-Rijal-2010
p1273
sg5
S'PMC2856397'
p1274
sg7
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p1275
sg9
V20419009.xml
p1276
sa(dp1277
g3
VSTD-Kotwal-1998
p1278
sg5
S'PMC2362603'
p1279
sg7
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p1280
sg9
V18493472.xml
p1281
sa(dp1282
g3
VSTD-Destura-unpublished
p1283
sg5
S'PMC543444'
p1284
sg7
VCD004827 v. 6.3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
p1285
sg9
V15546485.xml
p1286
sa(dp1287
g3
VSTD-Leach-2008
p1288
sg5
S'PMC2443129'
p1289
sg7
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p1290
sg9
V18513453.xml
p1291
sa(dp1292
g3
VSTD-Choung-2008
p1293
sg5
S'PMC2671765'
p1294
sg7
g1290
sg9
V19434268.xml
p1295
sa(dp1296
g3
VSTD-Huh-2009
p1297
sg5
S'PMC2688140'
p1298
sg7
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p1299
sg9
V19239703.xml
p1300
sa(dp1301
g3
VSTD-Bollen-2005
p1302
sg5
S'PMC1269459'
p1303
sg7
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p1304
sg9
V16137357.xml
p1305
sa(dp1306
g3
VSTD-Dyhr-2003
p1307
sg5
S'PMC154111'
p1308
sg7
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p1309
sg9
V12617741.xml
p1310
sa(dp1311
g3
VSTD-Makvandi-2011
p1312
sg5
S'PMC3081214'
p1313
sg7
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p1314
sg9
V21495198.xml
p1315
sa(dp1316
g3
VSTD-Vichinsky-2007
p1317
sg5
S'PMC1974786'
p1318
sg7
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p1319
sg9
V17233848.xml
p1320
sa(dp1321
g3
VSTD-Bafna-2011
p1322
sg5
S'PMC3146157'
p1323
sg7
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p1324
sg9
V21804705.xml
p1325
sa(dp1326
g3
VSTD-Montazeri-2011
p1327
sg5
S'PMC3252769'
p1328
sg7
g1324
sg9
V22247722.xml
p1329
sa(dp1330
g3
VSTD-Fujisaka-2011
p1331
sg5
S'PMC3241560'
p1332
sg7
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p1333
sg9
V21959870.xml
p1334
sa(dp1335
g3
VSTD-Thatcher-1999b
p1336
sg5
S'PMC2362337'
p1337
sg7
g1333
sg9
V10408844.xml
p1338
sa(dp1339
g3
VSTD-Thatcher-1999a
p1340
sg5
S'PMC2362337'
p1341
sg7
g1333
sg9
V10408844.xml
p1342
sa(dp1343
g3
VSTD-Boogaerts-2003
p1344
sg5
S'PMC2376376'
p1345
sg7
g1333
sg9
V12671693.xml
p1346
sa(dp1347
g3
VSTD-Smith-2003b
p1348
sg5
S'PMC2741110'
p1349
sg7
g1333
sg9
V12799626.xml
p1350
sa(dp1351
g3
VSTD-Smith-2003c
p1352
sg5
S'PMC2741110'
p1353
sg7
g1333
sg9
V12799626.xml
p1354
sa(dp1355
g3
VSTD-Smith-2003a
p1356
sg5
S'PMC2741110'
p1357
sg7
g1333
sg9
V12799626.xml
p1358
sa(dp1359
g3
VSTD-Wilkinson-2006
p1360
sg5
S'PMC2361228'
p1361
sg7
g1333
sg9
V16570051.xml
p1362
sa(dp1363
g3
VSTD-Pronzato-2010
p1364
sg5
S'PMC3228044'
p1365
sg7
g1333
sg9
V20798194.xml
p1366
sa(dp1367
g3
VSTD-Sweeney-1998
p1368
sg5
S'PMC2150364'
p1369
sg7
g1333
sg9
V9667681.xml
p1370
sa(dp1371
g3
VSTD-Thatcher-1999
p1372
sg5
S'PMC2362337'
p1373
sg7
g1333
sg9
V10408844.xml
p1374
sa(dp1375
g3
VSTD-Smith-2003
p1376
sg5
S'PMC2741110'
p1377
sg7
g1333
sg9
V12799626.xml
p1378
sa(dp1379
g3
VSTD-Boogaerts-Coiffier-2001
p1380
sg5
S'PMC2376376'
p1381
sg7
g1333
sg9
V12671693.xml
p1382
sa(dp1383
g3
VSTD-Amir-2004
p1384
sg5
S'PMC1630426'
p1385
sg7
VCD007239 v. 4.0 Interventions for preventing mastitis after childbirth.rm5
p1386
sg9
V17032458.xml
p1387
sa(dp1388
g3
VSTD-Galloway-2005
p1389
sg5
S'PMC1087493'
p1390
sg7
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p1391
sg9
V15804355.xml
p1392
sa(dp1393
g3
VSTD-Keystone-2009
p1394
sg5
S'PMC2674549'
p1395
sg7
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p1396
sg9
V19066176.xml
p1397
sa(dp1398
g3
VSTD-Jun-2006
p1399
sg5
S'PMC2722000'
p1400
sg7
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p1401
sg9
V17043424.xml
p1402
sa(dp1403
g3
VSTD-Mendoza-2009
p1404
sg5
S'PMC2680829'
p1405
sg7
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p1406
sg9
V19413910.xml
p1407
sa(dp1408
g3
VSTD-TAPESTRY-Dublin-2003
p1409
sg5
S'PMC3720922'
p1410
sg7
g1406
sg9
V23894666.xml
p1411
sa(dp1412
g3
VSTD-Gombocz-2007
p1413
sg5
S'PMC2206488'
p1414
sg7
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p1415
sg9
V17697359.xml
p1416
sa(dp1417
g3
VSTD-Akech-2006
p1418
sg5
S'PMC1569382'
p1419
sg7
g1415
sg9
V16998584.xml
p1420
sa(dp1421
g3
VSTD-Bent-2011
p1422
sg5
S'PMC3076562'
p1423
sg7
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p1424
sg9
V20683766.xml
p1425
sa(dp1426
g3
VSTD-Lou-C-2002
p1427
sg5
S'PMC3530567'
p1428
sg7
VCD001324 v. 10.0 Interventions for emergency contraception.rm5
p1429
sg9
V23300530.xml
p1430
sa(dp1431
g3
VSTD-Hellum-2011
p1432
sg5
S'PMC3100911'
p1433
sg7
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p1434
sg9
V21596740.xml
p1435
sa(dp1436
g3
VSTD-Ito-2010
p1437
sg5
S'PMC2972641'
p1438
sg7
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1439
sg9
V20049949.xml
p1440
sa(dp1441
g3
VSTD-Kane-2008a
p1442
sg5
S'PMC2770408'
p1443
sg7
g1439
sg9
V19920971.xml
p1444
sa(dp1445
g3
VSTD-Kamm-2008
p1446
sg5
S'PMC2564831'
p1447
sg7
g1439
sg9
V18272546.xml
p1448
sa(dp1449
g3
VSTD-Hawthorne-2011
p1450
sg5
S'PMC3746130'
p1451
sg7
g1439
sg9
V22081522.xml
p1452
sa(dp1453
g3
VSTD-Green-2010
p1454
sg5
S'PMC2890859'
p1455
sg7
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p1456
sg9
V20494434.xml
p1457
sa(dp1458
g3
VSTD-Kasari-2010
p1459
sg5
S'PMC2922697'
p1460
sg7
g1456
sg9
V20145986.xml
p1461
sa(dp1462
g3
VSTD-Bystrova-2008
p1463
sg5
S'PMC1878468'
p1464
sg7
VCD006641 v. 3.0 Separate care for new mother and infant versus rooming-in for increasing the duration of breastfeedi.rm5
p1465
sg9
V17488524.xml
p1466
sa(dp1467
g3
VSTD-Sesay-2011
p1468
sg5
S'PMC3024263'
p1469
sg7
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p1470
sg9
V21214940.xml
p1471
sa(dp1472
g3
VSTD-Konate-2011
p1473
sg5
S'PMC3032552'
p1474
sg7
g1470
sg9
V21304925.xml
p1475
sa(dp1476
g3
VSTD-Kweku-2008
p1477
sg5
S'PMC2602973'
p1478
sg7
g1470
sg9
V19098989.xml
p1479
sa(dp1480
g3
VSTD-Dicko-2011
p1481
sg5
S'PMC3032550'
p1482
sg7
g1470
sg9
V21304923.xml
p1483
sa(dp1484
g3
VSTD-Dicko-2008
p1485
sg5
S'PMC2500037'
p1486
sg7
g1470
sg9
V18611271.xml
p1487
sa(dp1488
g3
VSTD-Sandrini-2007
p1489
sg5
S'PMC1974802'
p1490
sg7
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p1491
sg9
V17627707.xml
p1492
sa(dp1493
g3
VSTD-Tfelt_x002d_Hansen-2006
p1494
sg5
S'PMC3452229'
p1495
sg7
g1491
sg9
V17164991.xml
p1496
sa(dp1497
g3
VSTD-Szewczyk-2010
p1498
sg5
S'PMC3298351'
p1499
sg7
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p1500
sg9
V22419941.xml
p1501
sa(dp1502
g3
VSTD-El_x002d_Bayoumi-2011
p1503
sg5
S'PMC3387601'
p1504
sg7
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p1505
sg9
V21745374.xml
p1506
sa(dp1507
g3
VSTD-Carlbring-2010
p1508
sg5
S'PMC2882846'
p1509
sg7
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p1510
sg9
V19967577.xml
p1511
sa(dp1512
g3
VSTD-Endres-2007
p1513
sg5
S'PMC3476149'
p1514
sg7
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p1515
sg9
V17955168.xml
p1516
sa(dp1517
g3
VSTD-Watts-1994
p1518
sg5
S'PMC2366143'
p1519
sg7
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p1520
sg9
V18472878.xml
p1521
sa(dp1522
g3
VSTD-Hibbard-1998
p1523
sg5
S'PMC1784771'
p1524
sg7
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p1525
sg9
V9678143.xml
p1526
sa(dp1527
g3
VSTD-Webster-2010a
p1528
sg5
S'PMC2958861'
p1529
sg7
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p1530
sg9
V20937130.xml
p1531
sa(dp1532
g3
VSTD-Colin-2007a
p1533
sg5
S'PMC2704535'
p1534
sg7
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p1535
sg9
V19668521.xml
p1536
sa(dp1537
g3
VSTD-Colin-2007b
p1538
sg5
S'PMC2704535'
p1539
sg7
g1535
sg9
V19668521.xml
p1540
sa(dp1541
g3
VSTD-Yamazaki-1984b
p1542
sg5
S'PMC3689032'
p1543
sg7
g1535
sg9
V23801989.xml
p1544
sa(dp1545
g3
VSTD-Kitano-1985
p1546
sg5
S'PMC3650034'
p1547
sg7
g1535
sg9
V23671647.xml
p1548
sa(dp1549
g3
VSTD-Yamazaki-1984c
p1550
sg5
S'PMC3689032'
p1551
sg7
g1535
sg9
V23801989.xml
p1552
sa(dp1553
g3
VSTD-Albrecht-2004
p1554
sg5
S'PMC2395315'
p1555
sg7
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p1556
sg9
V14710214.xml
p1557
sa(dp1558
g3
VSTD-Francini-1993
p1559
sg5
S'PMC1968505'
p1560
sg7
g1556
sg9
V8512828.xml
p1561
sa(dp1562
g3
VSTD-Fan-2009
p1563
sg5
S'PMC2781155'
p1564
sg7
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p1565
sg9
V19666658.xml
p1566
sa(dp1567
g3
VSTD-Tzanakis-2008
p1568
sg5
S'PMC2268719'
p1569
sg7
g1565
sg9
V18193489.xml
p1570
sa(dp1571
g3
VSTD-Schultz-2004
p1572
sg5
S'PMC394324'
p1573
sg7
VCD006634 v. 2.0 Probiotics for induction of remission in Crohn's disease.rm5
p1574
sg9
V15113451.xml
p1575
sa(dp1576
g3
VSTD-Block-1972
p1577
sg5
S'PMC3675863'
p1578
sg7
VCD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
p1579
sg9
V23761847.xml
p1580
sa(dp1581
g3
VSTD-Dietz-2010
p1582
sg5
S'PMC2808513'
p1583
sg7
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p1584
sg9
V19834635.xml
p1585
sa(dp1586
g3
VSTD-Carey-2009
p1587
sg5
S'PMC2774153'
p1588
sg7
g1584
sg9
V19583714.xml
p1589
sa(dp1590
g3
VSTD-Feary-2009a
p1591
sg5
S'PMC2728895'
p1592
sg7
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p1593
sg9
V19400893.xml
p1594
sa(dp1595
g3
VSTD-Perria-2007
p1596
sg5
S'PMC1904445'
p1597
sg7
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p1598
sg9
V17547760.xml
p1599
sa(dp1600
g3
VSTD-Carey-2005
p1601
sg5
S'PMC547907'
p1602
sg7
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p1603
sg9
V15667657.xml
p1604
sa(dp1605
g3
VSTD-Norrkoping
p1606
sg5
S'PMC3069219'
p1607
sg7
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p1608
sg9
V21454449.xml
p1609
sa(dp1610
g3
VSTD-Christopher-1998
p1611
sg5
S'PMC3654563'
p1612
sg7
VCD006546 v. 4.0 Kinship care for the safety permanency and well-being of children removed from the home for maltre.rm5
p1613
sg9
V23517028.xml
p1614
sa(dp1615
g3
VSTD-Rosen-1998
p1616
sg5
S'PMC3015270'
p1617
sg7
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p1618
sg9
V9876706.xml
p1619
sa(dp1620
g3
VSTD-Willems-2007a
p1621
sg5
S'PMC2000864'
p1622
sg7
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p1623
sg9
V17662113.xml
p1624
sa(dp1625
g3
VSTD-Sadighi-2006
p1626
sg5
S'PMC1693922'
p1627
sg7
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p1628
sg9
V17147808.xml
p1629
sa(dp1630
g3
VSTD-Moehler-2005
p1631
sg5
S'PMC2361806'
p1632
sg7
g1628
sg9
V15942629.xml
p1633
sa(dp1634
g3
VSTD-Pyrh_x00f6_nen-1995
p1635
sg5
S'PMC2033628'
p1636
sg7
g1628
sg9
V7533517.xml
p1637
sa(dp1638
g3
VSTD-de-Benedictis-1994b
p1639
sg5
S'PMC2365597'
p1640
sg7
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p1641
sg9
V18475602.xml
p1642
sa(dp1643
g3
VSTD-Bachewar-2009
p1644
sg5
S'PMC2825021'
p1645
sg7
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p1646
sg9
V20177574.xml
p1647
sa(dp1648
g3
VSTD-Popelut-2010
p1649
sg5
S'PMC2858083'
p1650
sg7
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p1651
sg9
V20422000.xml
p1652
sa(dp1653
g3
VSTD-Bero-2007
p1654
sg5
S'PMC1885451'
p1655
sg7
g1651
sg9
V17550302.xml
p1656
sa(dp1657
g3
VSTD-Clifford-2002
p1658
sg5
S'PMC126226'
p1659
sg7
g1651
sg9
V12213183.xml
p1660
sa(dp1661
g3
VSTD-Jefferson-2009
p1662
sg5
S'PMC2643439'
p1663
sg7
g1651
sg9
V19213766.xml
p1664
sa(dp1665
g3
VSTD-Rasmussen-2009
p1666
sg5
S'PMC2811705'
p1667
sg7
g1651
sg9
V20015404.xml
p1668
sa(dp1669
g3
VSTD-Rattinger-2009
p1670
sg5
S'PMC2688752'
p1671
sg7
g1651
sg9
V19503811.xml
p1672
sa(dp1673
g3
VSTD-Ekeberg-2009
p1674
sg5
S'PMC2769057'
p1675
sg7
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p1676
sg9
V19168537.xml
p1677
sa(dp1678
g3
VSTD-Xiao-2008
p1679
sg5
S'PMC2447617'
p1680
sg7
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p1681
sg9
V18447940.xml
p1682
sa(dp1683
g3
VSTD-Dalton-1962
p1684
sg5
S'PMC3557890'
p1685
sg7
VCD006175 v. 4.0 Progesterone for preventing pre-eclampsia and its complications.rm5
p1686
sg9
V23171812.xml
p1687
sa(dp1688
g3
VSTD-van-de-Vusse-2004
p1689
sg5
S'PMC523854'
p1690
sg7
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p1691
sg9
V15453912.xml
p1692
sa(dp1693
g3
VSTD-Rashidi-2011
p1694
sg5
S'PMC3446117'
p1695
sg7
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p1696
sg9
V23056757.xml
p1697
sa(dp1698
g3
VSTD-De-Benedictis-1994b
p1699
sg5
S'PMC2365597'
p1700
sg7
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p1701
sg9
V18475602.xml
p1702
sa(dp1703
g3
VSTD-Baradaran-2006
p1704
sg5
S'PMC1489930'
p1705
sg7
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p1706
sg9
V16709243.xml
p1707
sa(dp1708
g3
VSTD-Gray-1991
p1709
sg5
S'PMC1972556'
p1710
sg7
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p1711
sg9
V2069842.xml
p1712
sa(dp1713
g3
VSTD-Taal-2001
p1714
sg5
S'PMC2363941'
p1715
sg7
g1711
sg9
V11720425.xml
p1716
sa(dp1717
g3
VSTD-Feldman-2011
p1718
sg5
S'PMC3191344'
p1719
sg7
VCD009269 v. 2.2 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit d.rm5
p1720
sg9
V21849027.xml
p1721
sa(dp1722
g3
VSTD-Mikamo-_x0028_1_x0029_-1995
p1723
sg5
S'PMC2364408'
p1724
sg7
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p1725
sg9
V18475414.xml
p1726
sa(dp1727
g3
VSTD-Seidman-2005
p1728
sg5
S'PMC1784583'
p1729
sg7
g1725
sg9
V16338779.xml
p1730
sa(dp1731
g3
VSTD-Mikamo-_x0028_2_x0029_-1995
p1732
sg5
S'PMC2364408'
p1733
sg7
g1725
sg9
V18475414.xml
p1734
sa(dp1735
g3
VSTD-Menon-2007
p1736
sg5
S'PMC2636008'
p1737
sg7
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p1738
sg9
V17699944.xml
p1739
sa(dp1740
g3
VSTD-Luabeya-2007
p1741
sg5
S'PMC1891438'
p1742
sg7
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p1743
sg9
V17593956.xml
p1744
sa(dp1745
g3
VSTD-O_x0027_Connor-2009
p1746
sg5
S'PMC2699722'
p1747
sg7
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p1748
sg9
V19366977.xml
p1749
sa(dp1750
g3
VSTD-Schneider-2008
p1751
sg5
S'PMC2440309'
p1752
sg7
g1748
sg9
V18093108.xml
p1753
sa(dp1754
g3
VSTD-Foster-2007
p1755
sg5
S'PMC1868738'
p1756
sg7
g1748
sg9
V17456241.xml
p1757
sa(dp1758
g3
VSTD-Hemminki-2008
p1759
sg5
S'PMC2442595'
p1760
sg7
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p1761
sg9
V18547413.xml
p1762
sa(dp1763
g3
VSTD-Magpie-2006
p1764
sg5
S'PMC2063969'
p1765
sg7
VCD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
p1766
sg9
V17166221.xml
p1767
sa(dp1768
g3
VSTD-Kneyber-2009
p1769
sg5
S'PMC2717432'
p1770
sg7
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p1771
sg9
V19450268.xml
p1772
sa(dp1773
g3
VSTD-Razavi-2002
p1774
sg5
S'PMC2364281'
p1775
sg7
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p1776
sg9
V12085247.xml
p1777
sa(dp1778
g3
VSTD-Lienard-2010
p1779
sg5
S'PMC2906741'
p1780
sg7
g1776
sg9
V20628395.xml
p1781
sa(dp1782
g3
VSTD-Elsinga-2006
p1783
sg5
S'PMC1552064'
p1784
sg7
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p1785
sg9
V16824233.xml
p1786
sa(dp1787
g3
VSTD-Lumley-2006
p1788
sg5
S'PMC1712341'
p1789
sg7
g1785
sg9
V17156466.xml
p1790
sa(dp1791
g3
VSTD-Reis-Neto-2002
p1792
sg5
S'PMC3043413'
p1793
sg7
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p1794
sg9
V12113422.xml
p1795
sa(dp1796
g3
VSTD-Chen-2002
p1797
sg5
S'PMC3043440'
p1798
sg7
g1794
sg9
V12500834.xml
p1799
sa(dp1800
g3
VSTD-BRAIN-2009
p1801
sg5
S'PMC2794266'
p1802
sg7
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p1803
sg9
V19958521.xml
p1804
sa(dp1805
g3
VSTD-Riccardi-1994
p1806
sg5
S'PMC2033710'
p1807
sg7
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p1808
sg9
V7981078.xml
p1809
sa(dp1810
g3
VSTD-Riccardi-2000
p1811
sg5
S'PMC2374495'
p1812
sg7
g1808
sg9
V10755397.xml
p1813
sa(dp1814
g3
VSTD-Pfizer-2011
p1815
sg5
S'PMC2962290'
p1816
sg7
VCD010245 v. 3.0 Tranexamic acid for reducing mortality in emergency and urgent surgery.rm5
p1817
sg9
V21455360.xml
p1818
sa(dp1819
g3
VSTD-Icli-F-2005
p1820
sg5
S'PMC2361864'
p1821
sg7
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p1822
sg9
V15726120.xml
p1823
sa(dp1824
g3
VSTD-Fraser-S-1993
p1825
sg5
S'PMC1968186'
p1826
sg7
g1822
sg9
V8431375.xml
p1827
sa(dp1828
g3
VSTD-Bonneterre--J-2002
p1829
sg5
S'PMC2408916'
p1830
sg7
g1822
sg9
V12439707.xml
p1831
sa(dp1832
g3
VSTD-Rubens-RD-1975
p1833
sg5
S'PMC2025018'
p1834
sg7
g1822
sg9
V766800.xml
p1835
sa(dp1836
g3
VSTD-LEAD_x002d_3-2006
p1837
sg5
S'PMC3084519'
p1838
sg7
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p1839
sg9
V21205128.xml
p1840
sa(dp1841
g3
VSTD-Kanda-1998
p1842
sg5
S'PMC3699156'
p1843
sg7
g1839
sg9
V23943707.xml
p1844
sa(dp1845
g3
VSTD-Hewlett-1996
p1846
sg5
S'PMC3214045'
p1847
sg7
VCD003091 v. 5.2 Dressings for the prevention of surgical site infection.rm5
p1848
sg9
V22096550.xml
p1849
sa(dp1850
g3
VSTD-Calverley-2008
p1851
sg5
S'PMC2644301'
p1852
sg7
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p1853
sg9
V19014549.xml
p1854
sa(dp1855
g3
VSTD-Schermer-2009
p1856
sg5
S'PMC2793071'
p1857
sg7
g1853
sg9
V20037682.xml
p1858
sa(dp1859
g3
VSTD-Halm-2009
p1860
sg5
S'PMC2690844'
p1861
sg7
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p1862
sg9
V19259615.xml
p1863
sa(dp1864
g3
VSTD-Matsegui-2008
p1865
sg5
S'PMC2409363'
p1866
sg7
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p1867
sg9
V18503714.xml
p1868
sa(dp1869
g3
VSTD-Kofoed-2011
p1870
sg5
S'PMC3123603'
p1871
sg7
g1867
sg9
V21631932.xml
p1872
sa(dp1873
g3
VSTD-Meyer-2008
p1874
sg5
S'PMC2253708'
p1875
sg7
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p1876
sg9
V17995993.xml
p1877
sa(dp1878
g3
VSTD-Donskov_x0028_ii_x0029_-2005
p1879
sg5
S'PMC2361635'
p1880
sg7
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p1881
sg9
V16136045.xml
p1882
sa(dp1883
g3
VSTD-Jayson-1998
p1884
sg5
S'PMC2063040'
p1885
sg7
g1881
sg9
V9703284.xml
p1886
sa(dp1887
g3
VSTD-DeMulder-1995
p1888
sg5
S'PMC2033601'
p1889
sg7
g1881
sg9
V7841054.xml
p1890
sa(dp1891
g3
VSTD-Donskov_x0028_i_x0029_-2005
p1892
sg5
S'PMC2361635'
p1893
sg7
g1881
sg9
V16136045.xml
p1894
sa(dp1895
g3
VSTD-Henriksson-1998
p1896
sg5
S'PMC2150170'
p1897
sg7
g1881
sg9
V9579838.xml
p1898
sa(dp1899
g3
VSTD-Atzpodien-2001
p1900
sg5
S'PMC2375150'
p1901
sg7
g1881
sg9
V11710825.xml
p1902
sa(dp1903
g3
VSTD-Whittaker-2011
p1904
sg5
S'PMC3221331'
p1905
sg7
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p1906
sg9
V21371991.xml
p1907
sa(dp1908
g3
VSTD-Free-2011
p1909
sg5
S'PMC3143315'
p1910
sg7
g1906
sg9
V21722952.xml
p1911
sa(dp1912
g3
VSTD-COMPASS
p1913
sg5
S'PMC1920547'
p1914
sg7
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p1915
sg9
V17362472.xml
p1916
sa(dp1917
g3
VSTD-McMurdo-2009
p1918
sg5
S'PMC2639265'
p1919
sg7
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p1920
sg9
V19042940.xml
p1921
sa(dp1922
g3
VSTD-Young-2008
p1923
sg5
S'PMC2268921'
p1924
sg7
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p1925
sg9
V18304363.xml
p1926
sa(dp1927
g3
VSTD-Fretheim-2007
p1928
sg5
S'PMC1904466'
p1929
sg7
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p1930
sg9
V17622192.xml
p1931
sa(dp1932
g3
VSTD-Lee-2007
p1933
sg5
S'PMC2206510'
p1934
sg7
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p1935
sg9
V17705879.xml
p1936
sa(dp1937
g3
VSTD-Fagerstrom-2010
p1938
sg5
S'PMC2997603'
p1939
sg7
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p1940
sg9
V21134997.xml
p1941
sa(dp1942
g3
VSTD-White-2007
p1943
sg5
S'PMC1831486'
p1944
sg7
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p1945
sg9
V17359519.xml
p1946
sa(dp1947
g3
VSTD-Luabeya-2007
p1948
sg5
S'PMC1891438'
p1949
sg7
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p1950
sg9
V17593956.xml
p1951
sa(dp1952
g3
VSTD-Mohide-1996
p1953
sg5
S'PMC2074537'
p1954
sg7
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p1955
sg9
V8664135.xml
p1956
sa(dp1957
g3
VSTD-Hemsell-1993
p1958
sg5
S'PMC2364680'
p1959
sg7
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p1960
sg9
V18476202.xml
p1961
sa(dp1962
g3
VSTD-Leykin-2008
p1963
sg5
S'PMC2615351'
p1964
sg7
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p1965
sg9
V18581586.xml
p1966
sa(dp1967
g3
VSTD-Totapally-2002
p1968
sg5
S'PMC111183'
p1969
sg7
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p1970
sg9
V11983043.xml
p1971
sa(dp1972
g3
VSTD-Dent-2011
p1973
sg5
S'PMC3113983'
p1974
sg7
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p1975
sg9
V21542934.xml
p1976
sa(dp1977
g3
VSTD-Downer-1993
p1978
sg5
S'PMC1968469'
p1979
sg7
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p1980
sg9
V8494706.xml
p1981
sa(dp1982
g3
VSTD-Smith-2003
p1983
sg5
S'PMC2741110'
p1984
sg7
g1980
sg9
V12799626.xml
p1985
sa(dp1986
g3
VSTD-Boogaerts-2003
p1987
sg5
S'PMC2376376'
p1988
sg7
g1980
sg9
V12671693.xml
p1989
sa(dp1990
g3
VSTD-Thatcher-1999
p1991
sg5
S'PMC2362337'
p1992
sg7
g1980
sg9
V10408844.xml
p1993
sa(dp1994
g3
VSTD-Wilkinson-2006
p1995
sg5
S'PMC2361228'
p1996
sg7
g1980
sg9
V16570051.xml
p1997
sa(dp1998
g3
VSTD-Madlung_x002d_Kratzer-2009
p1999
sg5
S'PMC2773536'
p2000
sg7
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p2001
sg9
V19686525.xml
p2002
sa(dp2003
g3
VSTD-Carling-2009
p2004
sg5
S'PMC2724738'
p2005
sg7
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p2006
sg9
V19707575.xml
p2007
sa(dp2008
g3
VSTD-Carling-2008
p2009
sg5
S'PMC2585274'
p2010
sg7
g2006
sg9
V19030110.xml
p2011
sa(dp2012
g3
VSTD-Sharafi-2010
p2013
sg5
S'PMC3446002'
p2014
sg7
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p2015
sg9
V23056681.xml
p2016
sa(dp2017
g3
VSTD-Lorente-2006
p2018
sg5
S'PMC1750976'
p2019
sg7
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p2020
sg9
V16884530.xml
p2021
sa(dp2022
g3
VSTD-Thomachot-2001
p2023
sg5
S'PMC29053'
p2024
sg7
g2020
sg9
V11178222.xml
p2025
sa(dp2026
g3
VSTD-UK-ANZ-Trial-2011
p2027
sg5
S'PMC3018565'
p2028
sg7
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p2029
sg9
V21145284.xml
p2030
sa(dp2031
g3
VSTD-Vodermaier-2009
p2032
sg5
S'PMC2653746'
p2033
sg7
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p2034
sg9
V19209172.xml
p2035
sa(dp2036
g3
VSTD-Sheridan-2006
p2037
sg5
S'PMC1626460'
p2038
sg7
g2034
sg9
V17005051.xml
p2039
sa(dp2040
g3
VSTD-Thomson-2007
p2041
sg5
S'PMC1781432'
p2042
sg7
g2034
sg9
V17214891.xml
p2043
sa(dp2044
g3
VSTD-Hutchison-2007
p2045
sg5
S'PMC2360384'
p2046
sg7
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p2047
sg9
V17848908.xml
p2048
sa(dp2049
g3
VSTD-RESOLVE
p2050
sg5
S'PMC2963502'
p2051
sg7
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p2052
sg9
V20980427.xml
p2053
sa(dp2054
g3
VSTD-Dixon-1992
p2055
sg5
S'PMC1977824'
p2056
sg7
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p2057
sg9
V1503915.xml
p2058
sa(dp2059
g3
VSTD-Brookfield-2009
p2060
sg5
S'PMC2612742'
p2061
sg7
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p2062
sg9
V19125205.xml
p2063
sa(dp2064
g3
VSTD-Stockton-2000
p2065
sg5
S'PMC2363169'
p2066
sg7
g2062
sg9
V10638991.xml
p2067
sa(dp2068
g3
VSTD-Carling-2010
p2069
sg5
S'PMC2830888'
p2070
sg7
VCD006777 v. 3.0 Framing of health information messages.rm5
p2071
sg9
V20209127.xml
p2072
sa(dp2073
g3
VSTD-MacArthur-2009
p2074
sg5
S'PMC2636685'
p2075
sg7
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p2076
sg9
V19181730.xml
p2077
sa(dp2078
g3
VSTD-Arjyal-2011
p2079
sg5
S'PMC3108101'
p2080
sg7
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p2081
sg9
V21531174.xml
p2082
sa(dp2083
g3
VSTD-Pandit-2007-NPL
p2084
sg5
S'PMC1891439'
p2085
sg7
g2081
sg9
V17593957.xml
p2086
sa(dp2087
g3
VSTD-Dolecek-2008-VNM
p2088
sg5
S'PMC2374894'
p2089
sg7
g2081
sg9
V18493312.xml
p2090
sa(dp2091
g3
VSTD-Thunander-2010
p2092
sg5
S'PMC3022338'
p2093
sg7
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p2094
sg9
V21088056.xml
p2095
sa(dp2096
g3
VSTD-Hatch-2011
p2097
sg5
S'PMC3090298'
p2098
sg7
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p2099
sg9
V21573091.xml
p2100
sa(dp2101
g3
VSTD-Eddleston-2009
p2102
sg5
S'PMC2696321'
p2103
sg7
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p2104
sg9
V19564902.xml
p2105
sa(dp2106
g3
VSTD-Ried-2009
p2107
sg5
S'PMC2712451'
p2108
sg7
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p2109
sg9
V19583878.xml
p2110
sa(dp2111
g3
VSTD-Fraga-2005
p2112
sg5
S'PMC2270716'
p2113
sg7
g2109
sg9
V15712594.xml
p2114
sa(dp2115
g3
VSTD-Dickey-2003
p2116
sg5
S'PMC270000'
p2117
sg7
VCD005354 v. 7.0 Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology.rm5
p2118
sg9
V14609434.xml
p2119
sa(dp2120
g3
VSTD-DeWalt-2006
p2121
sg5
S'PMC1475568'
p2122
sg7
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p2123
sg9
V16533388.xml
p2124
sa(dp2125
g3
VSTD-Martins-2009
p2126
sg5
S'PMC2767482'
p2127
sg7
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p2128
sg9
V19858174.xml
p2129
sa(dp2130
g3
VSTD-Cockayne-2011
p2131
sg5
S'PMC3109952'
p2132
sg7
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p2133
sg9
V21652750.xml
p2134
sa(dp2135
g3
VSTD-Fuchs-2004
p2136
sg5
S'PMC2703213'
p2137
sg7
g2133
sg9
V19675691.xml
p2138
sa(dp2139
g3
VSTD-TXT-Group
p2140
sg5
S'PMC2408916'
p2141
sg7
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p2142
sg9
V12439707.xml
p2143
sa(dp2144
g3
VSTD-Talbot
p2145
sg5
S'PMC2375384'
p2146
sg7
g2142
sg9
V11986765.xml
p2147
sa(dp2148
g3
VSTD-Lindell-2008
p2149
sg5
S'PMC2649916'
p2150
sg7
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p2151
sg9
V19116007.xml
p2152
sa(dp2153
g3
VSTD-Kotwal-1998
p2154
sg5
S'PMC2362603'
p2155
sg7
VCD004843 v. 10.2 Music for pain relief.rm5
p2156
sg9
V18493472.xml
p2157
sa(dp2158
g3
VSTD-Vickers-2005
p2159
sg5
S'PMC1208905'
p2160
sg7
VCD005623 v. 7.0 Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-maligna.rm5
p2161
sg9
V16109163.xml
p2162
sa(dp2163
g3
VSTD-Rennard-2009
p2164
sg5
S'PMC3580134'
p2165
sg7
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p2166
sg9
V19368417.xml
p2167
sa(dp2168
g3
VSTD-Aranda-2006
p2169
sg5
S'PMC2360523'
p2170
sg7
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p2171
sg9
V16967054.xml
p2172
sa(dp2173
g3
VSTD-Jones-2008
p2174
sg5
S'PMC2556688'
p2175
sg7
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p2176
sg9
V18718012.xml
p2177
sa(dp2178
g3
VSTD-Kriemler-2010
p2179
sg5
S'PMC2827713'
p2180
sg7
g2176
sg9
V20179126.xml
p2181
sa(dp2182
g3
VSTD-Gentile-2009
p2183
sg5
S'PMC2758893'
p2184
sg7
g2176
sg9
V19765270.xml
p2185
sa(dp2186
g3
VSTD-Poikolainen-2008
p2187
sg5
S'PMC2265283'
p2188
sg7
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p2189
sg9
V18218147.xml
p2190
sa(dp2191
g3
VSTD-Fretheim-2006
p2192
sg5
S'PMC1472695'
p2193
sg7
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p2194
sg9
V16737346.xml
p2195
sa(dp2196
g3
VSTD-Cameron-2001
p2197
sg5
S'PMC2363881'
p2198
sg7
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p2199
sg9
V11379605.xml
p2200
sa(dp2201
g3
VSTD-Keiser-2005
p2202
sg5
S'PMC548524'
p2203
sg7
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p2204
sg9
V15647105.xml
p2205
sa(dp2206
g3
VSTD-Wang-2010
p2207
sg5
S'PMC3719192'
p2208
sg7
VCD005096 v. 8.2 Chinese herbal medicines for induction of remission in advanced or late gastric cancer.rm5
p2209
sg9
V23882420.xml
p2210
sa(dp2211
g3
VSTD-Xie-2006
p2212
sg5
S'PMC3747414'
p2213
sg7
g2209
sg9
V23983775.xml
p2214
sa(dp2215
g3
VSTD-Veldt-2003
p2216
sg5
S'PMC222984'
p2217
sg7
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p2218
sg9
V12948399.xml
p2219
sa(dp2220
g3
VSTD-O_x0027_Sullivan-2009
p2221
sg5
S'PMC2660391'
p2222
sg7
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p2223
sg9
V19318702.xml
p2224
sa(dp2225
g3
VSTD-Netherlands-1989
p2226
sg5
S'PMC3398037'
p2227
sg7
VCD004659 v. 5.0 Antiplatelet agents for preventing pre-eclampsia and its complications.rm5
p2228
sg9
V22815699.xml
p2229
sa(dp2230
g3
VSTD-MAINTAIN-Nephritis-Study
p2231
sg5
S'PMC3002764'
p2232
sg7
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p2233
sg9
V20833738.xml
p2234
sa(dp2235
g3
VSTD-Charles-2009
p2236
sg5
S'PMC2680945'
p2237
sg7
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p2238
sg9
V19435763.xml
p2239
sa(dp2240
g3
VSTD-Neuhaus-2009
p2241
sg5
S'PMC2634726'
p2242
sg7
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p2243
sg9
V19127261.xml
p2244
sa(dp2245
g3
VSTD-MAM-01-GOCSI
p2246
sg5
S'PMC2362097'
p2247
sg7
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p2248
sg9
V15668708.xml
p2249
sa(dp2250
g3
VSTD-Pakistan-2011
p2251
sg5
S'PMC3041931'
p2252
sg7
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p2253
sg9
V21176086.xml
p2254
sa(dp2255
g3
VSTD-Chen-2010
p2256
sg5
S'PMC2924475'
p2257
sg7
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p2258
sg9
V20724402.xml
p2259
sa(dp2260
g3
VSTD-Channabasavanna-1987
p2261
sg5
S'PMC3172444'
p2262
sg7
g2258
sg9
V21927264.xml
p2263
sa(dp2264
g3
VSTD-Pyrhonen-1997
p2265
sg5
S'PMC2223944'
p2266
sg7
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p2267
sg9
V9231932.xml
p2268
sa(dp2269
g3
VSTD-Fernandez-2010
p2270
sg5
S'PMC2898783'
p2271
sg7
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p2272
sg9
V20525274.xml
p2273
sa(dp2274
g3
VSTD-Chirico-2009
p2275
sg5
S'PMC2687544'
p2276
sg7
g2272
sg9
V19490659.xml
p2277
sa(dp2278
g3
VSTD-Bentley-2011
p2279
sg5
S'PMC3735492'
p2280
sg7
g2272
sg9
V23919494.xml
p2281
sa(dp2282
g3
VSTD-Nuijten-2010
p2283
sg5
S'PMC2816247'
p2284
sg7
g2272
sg9
V19967425.xml
p2285
sa(dp2286
g3
VSTD-Colford-2002
p2287
sg5
S'PMC2730258'
p2288
sg7
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p2289
sg9
V11749745.xml
p2290
sa(dp2291
g3
VSTD-Namutangula-2007
p2292
sg5
S'PMC2147028'
p2293
sg7
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p2294
sg9
V17958887.xml
p2295
sa(dp2296
g3
VSTD-Rosenson-2009
p2297
sg5
S'PMC2681027'
p2298
sg7
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p2299
sg9
V19265025.xml
p2300
sa(dp2301
g3
VSTD-Park-2010
p2302
sg5
S'PMC2829413'
p2303
sg7
g2299
sg9
V20195400.xml
p2304
sa(dp2305
g3
VSTD-Cho-2011
p2306
sg5
S'PMC3079135'
p2307
sg7
g2299
sg9
V21519514.xml
p2308
sa(dp2309
g3
VSTD-PULSAR--2006
p2310
sg5
S'PMC1779361'
p2311
sg7
g2299
sg9
V17184550.xml
p2312
sa(dp2313
g3
VSTD-Louie-2011
p2314
sg5
S'PMC3198285'
p2315
sg7
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p2316
sg9
V21900148.xml
p2317
sa(dp2318
g3
VSTD-Moses-2009
p2319
sg5
S'PMC2681032'
p2320
sg7
g2316
sg9
V19279301.xml
p2321
sa(dp2322
g3
VSTD-Hu-2005
p2323
sg5
S'PMC3776804'
p2324
sg7
VCD007796 v. 2.2 Chinese herbal medicine for diabetic peripheral neuropathy.rm5
p2325
sg9
V24058521.xml
p2326
sa(dp2327
g3
VSTD-Del-Giglio-2008
p2328
sg5
S'PMC2628928'
p2329
sg7
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p2330
sg9
V19014494.xml
p2331
sa(dp2332
g3
VSTD-Bakker-2007
p2333
sg5
S'PMC1885369'
p2334
sg7
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p2335
sg9
V17549228.xml
p2336
sa(dp2337
g3
VSTD-Oh-2010
p2338
sg5
S'PMC2826100'
p2339
sg7
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p2340
sg9
V19880433.xml
p2341
sa(dp2342
g3
VSTD-Sutherland-2005
p2343
sg5
S'PMC1087200'
p2344
sg7
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p2345
sg9
V15839740.xml
p2346
sa(dp2347
g3
VSTD-Taylor-2004
p2348
sg5
S'PMC539272'
p2349
sg7
VCD001270 v. 6.0 Teaching critical appraisal skills in healthcare settings.rm5
p2350
sg9
V15585061.xml
p2351
sa(dp2352
g3
VSTD-Eslami-2005
p2353
sg5
S'PMC1502073'
p2354
sg7
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p2355
sg9
V16943938.xml
p2356
sa(dp2357
g3
VSTD-Chavan-2010
p2358
sg5
S'PMC3034455'
p2359
sg7
g2355
sg9
V21358799.xml
p2360
sa(dp2361
g3
VSTD-FACS-2010
p2362
sg5
S'PMC2886041'
p2363
sg7
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p2364
sg9
V20500832.xml
p2365
sa(dp2366
g3
VSTD-Sims-2006
p2367
sg5
S'PMC1698486'
p2368
sg7
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p2369
sg9
V17134517.xml
p2370
sa(dp2371
g3
VSTD-Kluger-2007
p2372
sg5
S'PMC2206502'
p2373
sg7
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p2374
sg9
V17686152.xml
p2375
sa(dp2376
g3
VSTD-Sheikh-2002
p2377
sg5
S'PMC116603'
p2378
sg7
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p2379
sg9
V12079502.xml
p2380
sa(dp2381
g3
VSTD-Sokal-2004
p2382
sg5
S'PMC406425'
p2383
sg7
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p2384
sg9
V15056388.xml
p2385
sa(dp2386
g3
VSTD-Lofgren-2010
p2387
sg5
S'PMC2899760'
p2388
sg7
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p2389
sg9
V19763634.xml
p2390
sa(dp2391
g3
VSTD-Southampton
p2392
sg5
S'PMC1971367'
p2393
sg7
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p2394
sg9
V1691921.xml
p2395
sa(dp2396
g3
VSTD-RLW-8351
p2397
sg5
S'PMC1971367'
p2398
sg7
g2394
sg9
V1691921.xml
p2399
sa(dp2400
g3
VSTD-Manchester-1
p2401
sg5
S'PMC2374661'
p2402
sg7
g2394
sg9
V10945489.xml
p2403
sa(dp2404
g3
VSTD-Charleston-1996
p2405
sg5
S'PMC2364502'
p2406
sg7
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p2407
sg9
V18476110.xml
p2408
sa(dp2409
g3
VSTD-Lim-2009
p2410
sg5
S'PMC2687520'
p2411
sg7
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p2412
sg9
V19169651.xml
p2413
sa(dp2414
g3
VSTD-Itoh-2008
p2415
sg5
S'PMC2268695'
p2416
sg7
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p2417
sg9
V18312661.xml
p2418
sa(dp2419
g3
VSTD-Charron_x002d_Prochownik-2008
p2420
sg5
S'PMC2453657'
p2421
sg7
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p2422
sg9
V18411239.xml
p2423
sa(dp2424
g3
VSTD-Ringdal-1996
p2425
sg5
S'PMC2365805'
p2426
sg7
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p2427
sg9
V18475734.xml
p2428
sa(dp2429
g3
VSTD-Fonseca-2008
p2430
sg5
S'PMC2494667'
p2431
sg7
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p2432
sg9
V18458145.xml
p2433
sa(dp2434
g3
VSTD-Su-2012
p2435
sg5
S'PMC3674284'
p2436
sg7
VCD004547 v. 4.0 Chinese medicinal herbs for cholelithiasis.rm5
p2437
sg9
V23695700.xml
p2438
sa(dp2439
g3
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p2440
sg5
S'PMC2360162'
p2441
sg7
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p2442
sg9
V17375049.xml
p2443
sa(dp2444
g3
VSTD-Taal-2001-_x0028_NACCP_x0029_
p2445
sg5
S'PMC2363941'
p2446
sg7
g2442
sg9
V11720425.xml
p2447
sa(dp2448
g3
VSTD-Leon-2010
p2449
sg5
S'PMC2825497'
p2450
sg7
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p2451
sg9
V20205841.xml
p2452
sa(dp2453
g3
VSTD-Gregson-2007
p2454
sg5
S'PMC1831737'
p2455
sg7
g2451
sg9
V17388666.xml
p2456
sa(dp2457
g3
VSTD-Lorig-2010
p2458
sg5
S'PMC2875437'
p2459
sg7
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p2460
sg9
V20299481.xml
p2461
sa(dp2462
g3
VSTD-Quinn-2011
p2463
sg5
S'PMC3161305'
p2464
sg7
g2460
sg9
V21788632.xml
p2465
sa(dp2466
g3
VSTD-Lim-2011
p2467
sg5
S'PMC3024339'
p2468
sg7
g2460
sg9
V21270188.xml
p2469
sa(dp2470
g3
VSTD-Binnie-2007
p2471
sg5
S'PMC1871574'
p2472
sg7
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p2473
sg9
V17475005.xml
p2474
sa(dp2475
g3
VSTD-Nohlert-2009
p2476
sg5
S'PMC2685131'
p2477
sg7
g2473
sg9
V19405969.xml
p2478
sa(dp2479
g3
VSTD-van-Sprundel-2005
p2480
sg5
S'PMC2361560'
p2481
sg7
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p2482
sg9
V16052221.xml
p2483
sa(dp2484
g3
VSTD-Innes-2003
p2485
sg5
S'PMC2394220'
p2486
sg7
VCD003992 v. 6.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
p2487
sg9
V12838298.xml
p2488
sa(dp2489
g3
VSTD-Kitchener-2009
p2490
sg5
S'PMC2646126'
p2491
sg7
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p2492
sg9
V19070889.xml
p2493
sa(dp2494
g3
VSTD-Merenstein-2010
p2495
sg5
S'PMC2906750'
p2496
sg7
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p2497
sg9
V20485304.xml
p2498
sa(dp2499
g3
VSTD-West-2011
p2500
sg5
S'PMC3083335'
p2501
sg7
g2497
sg9
V21477383.xml
p2502
sa(dp2503
g3
VSTD-Mahalanabis-2008
p2504
sg5
S'PMC2396289'
p2505
sg7
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p2506
sg9
V18523643.xml
p2507
sa(dp2508
g3
VSTD-UK-PRECISE
p2509
sg5
S'PMC3446875'
p2510
sg7
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p2511
sg9
V23028897.xml
p2512
sa(dp2513
g3
VSTD-ANRS-1265
p2514
sg5
S'PMC1262556'
p2515
sg7
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p2516
sg9
V16231970.xml
p2517
sa(dp2518
g3
VSTD-Leach-2008
p2519
sg5
S'PMC2443129'
p2520
sg7
VCD004401 v. 9.2 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
p2521
sg9
V18513453.xml
p2522
sa(dp2523
g3
VSTD-Dube-1981
p2524
sg5
S'PMC3012941'
p2525
sg7
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p2526
sg9
V22058537.xml
p2527
sa(dp2528
g3
VSTD-Kuna-2007
p2529
sg5
S'PMC1920547'
p2530
sg7
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p2531
sg9
V17362472.xml
p2532
sa(dp2533
g3
VSTD-Maspero-2010
p2534
sg5
S'PMC2993043'
p2535
sg7
g2531
sg9
V20874458.xml
p2536
sa(dp2537
g3
VSTD-Wheatley-1969-b
p2538
sg5
S'PMC3606375'
p2539
sg7
VCD006722 v. 3.0 Psychostimulants for depression.rm5
p2540
sg9
V23522244.xml
p2541
sa(dp2542
g3
VSTD-Wheatley-1969-a
p2543
sg5
S'PMC3606375'
p2544
sg7
g2540
sg9
V23522244.xml
p2545
sa(dp2546
g3
VSTD-Jimenez-2007
p2547
sg5
S'PMC2246206'
p2548
sg7
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p2549
sg9
V17988379.xml
p2550
sa(dp2551
g3
VSTD-Apostolakis-2008
p2552
sg5
S'PMC2287179'
p2553
sg7
g2549
sg9
V18361800.xml
p2554
sa(dp2555
g3
VSTD-Estonian-blind-trial
p2556
sg5
S'PMC2702282'
p2557
sg7
VCD009672 v. 2.0 Hormone therapy for sexual function in perimenopausal and postmenopausal women.rm5
p2558
sg9
V19505307.xml
p2559
sa(dp2560
g3
VSTD-Estonian-non_x002d_blind-trial
p2561
sg5
S'PMC2702282'
p2562
sg7
g2558
sg9
V19505307.xml
p2563
sa(dp2564
g3
VSTD-Peng-2011
p2565
sg5
S'PMC3177872'
p2566
sg7
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p2567
sg9
V21835046.xml
p2568
sa(dp2569
g3
VSTD-Allal-2000
p2570
sg5
S'PMC2363346'
p2571
sg7
g2567
sg9
V10735495.xml
p2572
sa(dp2573
g3
VSTD-Campos_x002d_Lobato-2011
p2574
sg5
S'PMC3129949'
p2575
sg7
g2567
sg9
V21808871.xml
p2576
sa(dp2577
g3
VSTD-SPHERE
p2578
sg5
S'PMC2770592'
p2579
sg7
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p2580
sg9
V19875426.xml
p2581
sa(dp2582
g3
VSTD-Mutrie-1988
p2583
sg5
S'PMC3505536'
p2584
sg7
VCD004366 v. 11.2 Exercise for depression.rm5
p2585
sg9
V22836201.xml
p2586
sa(dp2587
g3
VSTD-Pilu-2007
p2588
sg5
S'PMC1976311'
p2589
sg7
g2585
sg9
V17620123.xml
p2590
sa(dp2591
g3
VSTD-Kumagai-1999
p2592
sg5
S'PMC3589943'
p2593
sg7
VCD003438 v. 9.8 Interventions for increasing pedestrian and cyclist visibility for the prevention of death and injur.rm5
p2594
sg9
V23263729.xml
p2595
sa(dp2596
g3
VSTD-Kataoka-2010
p2597
sg5
S'PMC3017017'
p2598
sg7
VCD007007 v. 3.0 Screening women for intimate partner violence in healthcare settings.rm5
p2599
sg9
V21182802.xml
p2600
sa(dp2601
g3
VSTD-Chaney-2011
p2602
sg5
S'PMC3219630'
p2603
sg7
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p2604
sg9
V22032247.xml
p2605
sa(dp2606
g3
VSTD-Landis-2007
p2607
sg5
S'PMC1838423'
p2608
sg7
g2604
sg9
V17338822.xml
p2609
sa(dp2610
g3
VSTD-Richards-2012
p2611
sg5
S'PMC2770465'
p2612
sg7
g2604
sg9
V19832996.xml
p2613
sa(dp2614
g3
VSTD-Waitzkin-2011
p2615
sg5
S'PMC3051073'
p2616
sg7
g2604
sg9
V20882400.xml
p2617
sa(dp2618
g3
VSTD-Buszewicz-2010
p2619
sg5
S'PMC2923105'
p2620
sg7
g2604
sg9
V20684786.xml
p2621
sa(dp2622
g3
VSTD-Ell-2010
p2623
sg5
S'PMC2845010'
p2624
sg7
g2604
sg9
V20097780.xml
p2625
sa(dp2626
g3
VSTD-Lopez_x002d_Pousa-2005
p2627
sg5
S'PMC3546803'
p2628
sg7
VCD001191 v. 16.4 Rivastigmine for Alzheimer's disease.rm5
p2629
sg9
V23341737.xml
p2630
sa(dp2631
g3
VSTD-Saxena-2009
p2632
sg5
S'PMC2900101'
p2633
sg7
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p2634
sg9
V20640118.xml
p2635
sa(dp2636
g3
VSTD-Yildiz-2002
p2637
sg5
S'PMC125315'
p2638
sg7
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p2639
sg9
V12133187.xml
p2640
sa(dp2641
g3
VSTD-Uludag-2009
p2642
sg5
S'PMC3015970'
p2643
sg7
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p2644
sg9
V19793473.xml
p2645
sa(dp2646
g3
VSTD-Spittle-2009a
p2647
sg5
S'PMC2797495'
p2648
sg7
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p2649
sg9
V19954550.xml
p2650
sa(dp2651
g3
VSTD-Taniguchi-2009
p2652
sg5
S'PMC2688118'
p2653
sg7
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p2654
sg9
V19171056.xml
p2655
sa(dp2656
g3
VSTD-Houghton-2007
p2657
sg5
S'PMC1971055'
p2658
sg7
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p2659
sg9
V17629923.xml
p2660
sa(dp2661
g3
VSTD-Dippel-2003a
p2662
sg5
S'PMC101394'
p2663
sg7
VCD001247 v. 7.3 Cooling therapy for acute stroke.rm5
p2664
sg9
V11918829.xml
p2665
sa(dp2666
g3
VSTD-Spiro-1989
p2667
sg5
S'PMC2247136'
p2668
sg7
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p2669
sg9
V2540788.xml
p2670
sa(dp2671
g3
VSTD-Wintzen-2007
p2672
sg5
S'PMC1915648'
p2673
sg7
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p2674
sg9
V17285226.xml
p2675
sa(dp2676
g3
VSTD-Koninckx-2008
p2677
sg5
S'PMC2517154'
p2678
sg7
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p2679
sg9
V18556683.xml
p2680
sa(dp2681
g3
VSTD-Dondorp-2010
p2682
sg5
S'PMC3033534'
p2683
sg7
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p2684
sg9
V21062666.xml
p2685
sa(dp2686
g3
VSTD-De-Jong-2008
p2687
sg5
S'PMC2194921'
p2688
sg7
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p2689
sg9
V18213383.xml
p2690
sa(dp2691
g3
VSTD-Amirabdollahian-2007
p2692
sg5
S'PMC1819386'
p2693
sg7
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p2694
sg9
V17309791.xml
p2695
sa(dp2696
g3
VSTD-Kahn-2006
p2697
sg5
S'PMC1550245'
p2698
sg7
g2694
sg9
V16790067.xml
p2699
sa(dp2700
g3
VSTD-Ziaei-2010a
p2701
sg5
S'PMC3719303'
p2702
sg7
VCD008536 v. 3.3 Short and long term effects of tibolone in postmenopausal women.rm5
p2703
sg9
V23926488.xml
p2704
sa(dp2705
g3
VSTD-Redmond-2004
p2706
sg5
S'PMC2553778'
p2707
sg7
VCD006973 v. 3.0 Interventions for increasing ankle range of motion in patients with neuromuscular disease.rm5
p2708
sg9
V18822155.xml
p2709
sa(dp2710
g3
VSTD-Murthy-1991
p2711
sg5
S'PMC2988295'
p2712
sg7
VCD007139 v. 3.0 Alprazolam for depression.rm5
p2713
sg9
V21897464.xml
p2714
sa(dp2715
g3
VSTD-Jhanji-2010
p2716
sg5
S'PMC2945135'
p2717
sg7
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p2718
sg9
V20698956.xml
p2719
sa(dp2720
g3
VSTD-Cecconi-2011
p2721
sg5
S'PMC3218998'
p2722
sg7
g2718
sg9
V21624138.xml
p2723
sa(dp2724
g3
VSTD-Pearse-2005
p2725
sg5
S'PMC1414018'
p2726
sg7
g2718
sg9
V16356219.xml
p2727
sa(dp2728
g3
VSTD-Mayer-2010
p2729
sg5
S'PMC2875533'
p2730
sg7
g2718
sg9
V20156348.xml
p2731
sa(dp2732
g3
VSTD-Cote-1998
p2733
sg5
S'PMC2063039'
p2734
sg7
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p2735
sg9
V9703292.xml
p2736
sa(dp2737
g3
VSTD-Unrod-2007
p2738
sg5
S'PMC1829425'
p2739
sg7
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p2740
sg9
V17372796.xml
p2741
sa(dp2742
g3
VSTD-Clifford-2002
p2743
sg5
S'PMC126226'
p2744
sg7
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p2745
sg9
V12213183.xml
p2746
sa(dp2747
g3
VSTD-Leehey-2009
p2748
sg5
S'PMC2796994'
p2749
sg7
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p2750
sg9
V20003224.xml
p2751
sa(dp2752
g3
VSTD-Baer-2005
p2753
sg5
S'PMC1201146'
p2754
sg7
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p2755
sg9
V16086839.xml
p2756
sa(dp2757
g3
VSTD-Howard-1974
p2758
sg5
S'PMC3760896'
p2759
sg7
VCD003082 v. 12.0 Haloperidol versus placebo for schizophrenia.rm5
p2760
sg9
V24019874.xml
p2761
sa(dp2762
g3
VSTD-Cowett-1977
p2763
sg5
S'PMC2595562'
p2764
sg7
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p2765
sg9
V602256.xml
p2766
sa(dp2767
g3
VSTD-Stepnowsky-2007
p2768
sg5
S'PMC1874716'
p2769
sg7
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p2770
sg9
V17513285.xml
p2771
sa(dp2772
g3
VSTD-Halpern-2008
p2773
sg5
S'PMC2582655'
p2774
sg7
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p2775
sg9
V19023429.xml
p2776
sa(dp2777
g3
VSTD-Peterson-2007
p2778
sg5
S'PMC2129116'
p2779
sg7
g2775
sg9
V18091987.xml
p2780
sa(dp2781
g3
VSTD-McCormack-2010
p2782
sg5
S'PMC2956883'
p2783
sg7
g2775
sg9
V20851460.xml
p2784
sa(dp2785
g3
VSTD-Feldblum-2008
p2786
sg5
S'PMC2190795'
p2787
sg7
g2775
sg9
V18213382.xml
p2788
sa(dp2789
g3
VSTD-Ahmedzai-2004
p2790
sg5
S'PMC2409543'
p2791
sg7
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p2792
sg9
V14735178.xml
p2793
sa(dp2794
g3
VSTD-Innes-2007
p2795
sg5
S'PMC2265270'
p2796
sg7
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p2797
sg9
V18096042.xml
p2798
sa(dp2799
g3
VSTD-Xue-2004
p2800
sg5
S'PMC3772925'
p2801
sg7
VCD007503 v. 3.0 Antidepressants for depression in physically ill people.rm5
p2802
sg9
V24058553.xml
p2803
sa(dp2804
g3
VSTD-Londahl-2010
p2805
sg5
S'PMC2858204'
p2806
sg7
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p2807
sg9
V20427683.xml
p2808
sa(dp2809
g3
VSTD-Nguyen-2008
p2810
sg5
S'PMC2483918'
p2811
sg7
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p2812
sg9
V18417444.xml
p2813
sa(dp2814
g3
VSTD-N0265041749
p2815
sg5
S'PMC3195130'
p2816
sg7
VCD004626 v. 10.7 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high.rm5
p2817
sg9
V22022003.xml
p2818
sa(dp2819
g3
VSTD-Wyman-1987
p2820
sg5
S'PMC3384962'
p2821
sg7
VCD004374 v. 3.0 Short term urinary catheter policies following urogenital surgery in adults.rm5
p2822
sg9
V22778750.xml
p2823
sa(dp2824
g3
VSTD-GICOG
p2825
sg5
S'PMC2360651'
p2826
sg7
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p2827
sg9
V16868539.xml
p2828
sa(dp2829
g3
VSTD-Oosterhof-2006
p2830
sg5
S'PMC3476076'
p2831
sg7
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p2832
sg9
V16897618.xml
p2833
sa(dp2834
g3
VSTD-Goldstein-1986
p2835
sg5
S'PMC3516240'
p2836
sg7
VCD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
p2837
sg9
V23259013.xml
p2838
sa(dp2839
g3
VSTD-Briggs-1984
p2840
sg5
S'PMC3765382'
p2841
sg7
VCD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
p2842
sg9
V23902583.xml
p2843
sa(dp2844
g3
VSTD-Van-Koningsveld-2004
p2845
sg5
S'PMC2778673'
p2846
sg7
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p2847
sg9
V17426908.xml
p2848
sa(dp2849
g3
VSTD-Ye-LJ-2000
p2850
sg5
S'PMC2961892'
p2851
sg7
VCD004116 v. 6.0 Herbal medicines for treatment of irritable bowel syndrome.rm5
p2852
sg9
V21202743.xml
p2853
sa(dp2854
g3
VSTD-Gu-XX-1999
p2855
sg5
S'PMC1810433'
p2856
sg7
g2852
sg9
V17375186.xml
p2857
sa(dp2858
g3
VSTD-Xu-XP-2002
p2859
sg5
S'PMC3702287'
p2860
sg7
g2852
sg9
V23788040.xml
p2861
sa(dp2862
g3
VSTD-Wyman-1987
p2863
sg5
S'PMC3384962'
p2864
sg7
VCD004011 v. 5.0 Strategies for the removal of short-term indwelling urethral catheters in adults.rm5
p2865
sg9
V22778750.xml
p2866
sa(dp2867
g3
VSTD-Worth-2009
p2868
sg5
S'PMC2720945'
p2869
sg7
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p2870
sg9
V19624838.xml
p2871
sa(dp2872
g3
VSTD-Moroni-1996
p2873
sg5
S'PMC2074576'
p2874
sg7
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p2875
sg9
V8688342.xml
p2876
sa(dp2877
g3
VSTD-Webster-2008
p2878
sg5
S'PMC2483870'
p2879
sg7
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p2880
sg9
V18614482.xml
p2881
sa(dp2882
g3
VSTD-Rickard-2010
p2883
sg5
S'PMC2944158'
p2884
sg7
g2880
sg9
V20831782.xml
p2885
sa(dp2886
g3
VSTD-Henker-2007a
p2887
sg5
S'PMC1802727'
p2888
sg7
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p2889
sg9
V17287932.xml
p2890
sa(dp2891
g3
VSTD-Frigerio-1986
p2892
sg5
S'PMC2171037'
p2893
sg7
g2889
sg9
V17760859.xml
p2894
sa(dp2895
g3
VSTD-Delvaux-2004
p2896
sg5
S'PMC2395320'
p2897
sg7
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p2898
sg9
V14710215.xml
p2899
sa(dp2900
g3
VSTD-Tehraninejad-2010
p2901
sg5
S'PMC3302709'
p2902
sg7
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p2903
sg9
V22427771.xml
p2904
sa(dp2905
g3
VSTD-Turpeinen-2008
p2906
sg5
S'PMC2532957'
p2907
sg7
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p2908
sg9
V17634183.xml
p2909
sa(dp2910
g3
VSTD-ICSS-2010
p2911
sg5
S'PMC2849002'
p2912
sg7
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p2913
sg9
V20189239.xml
p2914
sa(dp2915
g3
VSTD-Lenssen-2008
p2916
sg5
S'PMC2386789'
p2917
sg7
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p2918
sg9
V18442423.xml
p2919
sa(dp2920
g3
VSTD-Lenssen-2003
p2921
sg5
S'PMC1403777'
p2922
sg7
g2918
sg9
V16504087.xml
p2923
sa(dp2924
g3
VSTD-Li--2003
p2925
sg5
S'PMC3707322'
p2926
sg7
VCD006633 v. 5.0 Clozapine versus other atypical antipsychotics for schizophrenia.rm5
p2927
sg9
V23869281.xml
p2928
sa(dp2929
g3
VSTD-Fern_x00e1_ndez-2009
p2930
sg5
S'PMC2621339'
p2931
sg7
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p2932
sg9
V19165321.xml
p2933
sa(dp2934
g3
VSTD-Gal_x00e1_n-2007
p2935
sg5
S'PMC2034550'
p2936
sg7
g2932
sg9
V17760974.xml
p2937
sa(dp2938
g3
VSTD-Alsaedi-2009
p2939
sg5
S'PMC2813645'
p2940
sg7
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p2941
sg9
V19448377.xml
p2942
sa(dp2943
g3
VSTD-Slater-2010
p2944
sg5
S'PMC2958259'
p2945
sg7
g2941
sg9
V20817247.xml
p2946
sa(dp2947
g3
VSTD-Tonnel-2008
p2948
sg5
S'PMC2629970'
p2949
sg7
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p2950
sg9
V18686739.xml
p2951
sa(dp2952
g3
VSTD-Bateman-2010b
p2953
sg5
S'PMC2921687'
p2954
sg7
g2950
sg9
V20714373.xml
p2955
sa(dp2956
g3
VSTD-Freeman-2007
p2957
sg5
S'PMC1913915'
p2958
sg7
g2950
sg9
V17605774.xml
p2959
sa(dp2960
g3
VSTD-Trooster-2011
p2961
sg5
S'PMC3078679'
p2962
sg7
g2950
sg9
V21503263.xml
p2963
sa(dp2964
g3
VSTD-Cooper-2010
p2965
sg5
S'PMC2981152'
p2966
sg7
g2950
sg9
V21103404.xml
p2967
sa(dp2968
g3
VSTD-Guyot-2003
p2969
sg5
S'PMC222910'
p2970
sg7
VCD008054 v. 2.2 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.rm5
p2971
sg9
V14511396.xml
p2972
sa(dp2973
g3
VSTD-Choung-2008
p2974
sg5
S'PMC2671765'
p2975
sg7
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p2976
sg9
V19434268.xml
p2977
sa(dp2978
g3
VSTD-Bertuzzi-2003
p2979
sg5
S'PMC2394317'
p2980
sg7
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p2981
sg9
V14520438.xml
p2982
sa(dp2983
g3
VSTD-Leung-2006
p2984
sg5
S'PMC1804104'
p2985
sg7
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p2986
sg9
V17176279.xml
p2987
sa(dp2988
g3
VSTD-Katiyar-2006
p2989
sg5
S'PMC2856361'
p2990
sg7
VCD008250 v. 2.0 Breathing exercises for chronic obstructive pulmonary disease.rm5
p2991
sg9
V20418993.xml
p2992
sa(dp2993
g3
VSTD-Scabini-2010
p2994
sg5
S'PMC2873340'
p2995
sg7
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p2996
sg9
V20433721.xml
p2997
sa(dp2998
g3
VSTD-Syed-2006
p2999
sg5
S'PMC3001155'
p3000
sg7
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p3001
sg9
V17591348.xml
p3002
sa(dp3003
g3
VSTD-Bhutta-2010
p3004
sg5
S'PMC3700035'
p3005
sg7
g3001
sg9
V23826502.xml
p3006
sa(dp3007
g3
VSTD-Bari-2006
p3008
sg5
S'PMC3001156'
p3009
sg7
g3001
sg9
V17591349.xml
p3010
sa(dp3011
g3
VSTD-Maruyama-2010
p3012
sg5
S'PMC2834887'
p3013
sg7
VCD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
p3014
sg9
V20211953.xml
p3015
sa(dp3016
g3
VSTD-Tweyongyere-2009-UGA
p3017
sg5
S'PMC2666740'
p3018
sg7
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p3019
sg9
V19296834.xml
p3020
sa(dp3021
g3
VSTD-Olliaro-2011-TZA
p3022
sg5
S'PMC3114749'
p3023
sg7
g3019
sg9
V21695161.xml
p3024
sa(dp3025
g3
VSTD-Olliaro-2011-MRT
p3026
sg5
S'PMC3114749'
p3027
sg7
g3019
sg9
V21695161.xml
p3028
sa(dp3029
g3
VSTD-Olliaro-2011-BRA
p3030
sg5
S'PMC3114749'
p3031
sg7
g3019
sg9
V21695161.xml
p3032
sa(dp3033
g3
VSTD-Bergstrom-2009
p3034
sg5
S'PMC2759981'
p3035
sg7
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p3036
sg9
V19538406.xml
p3037
sa(dp3038
g3
VSTD-Fiocchi-1994
p3039
sg5
S'PMC2365600'
p3040
sg7
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p3041
sg9
V18475604.xml
p3042
sa(dp3043
g3
VSTD-Kouyate-2008
p3044
sg5
S'PMC2287184'
p3045
sg7
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p3046
sg9
V18364043.xml
p3047
sa(dp3048
g3
VSTD-MacArthur-2009
p3049
sg5
S'PMC2636685'
p3050
sg7
g3046
sg9
V19181730.xml
p3051
sa(dp3052
g3
VSTD-Bari-2006
p3053
sg5
S'PMC3001156'
p3054
sg7
g3046
sg9
V17591349.xml
p3055
sa(dp3056
g3
VSTD-Dennis-2009
p3057
sg5
S'PMC2628301'
p3058
sg7
g3046
sg9
V19147637.xml
p3059
sa(dp3060
g3
VSTD-Zaman-2008
p3061
sg5
S'PMC2740673'
p3062
sg7
g3046
sg9
V18686554.xml
p3063
sa(dp3064
g3
VSTD-Karatzas-2002
p3065
sg5
S'PMC153443'
p3066
sg7
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p3067
sg9
V12512504.xml
p3068
sa(dp3069
g3
VSTD-Tugrul-2002
p3070
sg5
S'PMC125317'
p3071
sg7
g3067
sg9
V12225613.xml
p3072
sa(dp3073
g3
VSTD-Campbell-2008
p3074
sg5
S'PMC2387195'
p3075
sg7
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p3076
sg9
V18468543.xml
p3077
sa(dp3078
g3
VSTD-Johnson-2009
p3079
sg5
S'PMC2681204'
p3080
sg7
g3076
sg9
V19440519.xml
p3081
sa(dp3082
g3
VSTD-Edwards-1996
p3083
sg5
S'PMC2364515'
p3084
sg7
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p3085
sg9
V18476121.xml
p3086
sa(dp3087
g3
VSTD-Martin-1997
p3088
sg5
S'PMC2364533'
p3089
sg7
g3085
sg9
V18476128.xml
p3090
sa(dp3091
g3
VSTD-Rosenn-1995
p3092
sg5
S'PMC2364446'
p3093
sg7
g3085
sg9
V18476049.xml
p3094
sa(dp3095
g3
VSTD-Turrentine-1995
p3096
sg5
S'PMC2364394'
p3097
sg7
g3085
sg9
V18475393.xml
p3098
sa(dp3099
g3
VSTD-Khanna-2005
p3100
sg5
S'PMC1156915'
p3101
sg7
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p3102
sg9
V15946379.xml
p3103
sa(dp3104
g3
VSTD-Hopewell-2004
p3105
sg5
S'PMC3646177'
p3106
sg7
VMR000010 v. 6.0 Grey literature in meta-analyses of randomized trials of health care interventions.rm5
p3107
sg9
V23645909.xml
p3108
sa(dp3109
g3
VSTD-Smithuis-2010-MMR
p3110
sg5
S'PMC2947715'
p3111
sg7
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p3112
sg9
V20832366.xml
p3113
sa(dp3114
g3
VSTD-Awab-2010-AFG
p3115
sg5
S'PMC2864284'
p3116
sg7
g3112
sg9
V20409302.xml
p3117
sa(dp3118
g3
VSTD-Hutagalung-2005-THA
p3119
sg5
S'PMC1261533'
p3120
sg7
g3112
sg9
V16179089.xml
p3121
sa(dp3122
g3
VSTD-Poravuth-2010-ASIA
p3123
sg5
S'PMC3022577'
p3124
sg7
g3112
sg9
V21267072.xml
p3125
sa(dp3126
g3
VSTD-Kralikova-2009
p3127
sg5
S'PMC2792228'
p3128
sg7
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p3129
sg9
V19943947.xml
p3130
sa(dp3131
g3
VSTD-Paxton-1980
p3132
sg5
S'PMC3633932'
p3133
sg7
VCD004307 v. 10.0 Competitions and incentives for smoking cessation.rm5
p3134
sg9
V23626740.xml
p3135
sa(dp3136
g3
VSTD-Thorstensson-2005
p3137
sg5
S'PMC1187893'
p3138
sg7
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p3139
sg9
V15924620.xml
p3140
sa(dp3141
g3
VSTD-Zorlu-2005
p3142
sg5
S'PMC3015649'
p3143
sg7
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p3144
sg9
V16381364.xml
p3145
sa(dp3146
g3
VSTD-Misra-2007
p3147
sg5
S'PMC3476139'
p3148
sg7
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p3149
sg9
V17563841.xml
p3150
sa(dp3151
g3
VSTD-De-La-Rosa-2008
p3152
sg5
S'PMC2592751'
p3153
sg7
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p3154
sg9
V18799004.xml
p3155
sa(dp3156
g3
VSTD-Chan-2008
p3157
sg5
S'PMC2671976'
p3158
sg7
g3154
sg9
V19142552.xml
p3159
sa(dp3160
g3
VSTD-Hoskins-2008
p3161
sg5
S'PMC3204266'
p3162
sg7
VCD006782 v. 4.0 Interventions for preventing hamstring injuries.rm5
p3163
sg9
V21967753.xml
p3164
sa(dp3165
g3
VSTD-Li-2008
p3166
sg5
S'PMC2597744'
p3167
sg7
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p3168
sg9
V19081791.xml
p3169
sa(dp3170
g3
VSTD-Liu-LY-2010
p3171
sg5
S'PMC3759346'
p3172
sg7
VCD005292 v. 5.2 Herbal preparations for uterine fibroids.rm5
p3173
sg9
V23813869.xml
p3174
sa(dp3175
g3
VSTD-Zhu-FH-2006
p3176
sg5
S'PMC2960419'
p3177
sg7
g3173
sg9
V21201460.xml
p3178
sa(dp3179
g3
VSTD-Wattchow-2006
p3180
sg5
S'PMC2361245'
p3181
sg7
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p3182
sg9
V16622437.xml
p3183
sa(dp3184
g3
VSTD-Russell_x002d_Jones-2009
p3185
sg5
S'PMC2744824'
p3186
sg7
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p3187
sg9
V19688338.xml
p3188
sa(dp3189
g3
VSTD-Home-2007
p3190
sg5
S'PMC1974817'
p3191
sg7
g3187
sg9
V17403121.xml
p3192
sa(dp3193
g3
VSTD-Zinman-2009
p3194
sg5
S'PMC2699702'
p3195
sg7
g3187
sg9
V19289857.xml
p3196
sa(dp3197
g3
VSTD-List-2009
p3198
sg5
S'PMC2660449'
p3199
sg7
g3187
sg9
V19114612.xml
p3200
sa(dp3201
g3
VSTD-Nauck-2009b
p3202
sg5
S'PMC2699710'
p3203
sg7
g3187
sg9
V19366970.xml
p3204
sa(dp3205
g3
VSTD-Nauck-2009a
p3206
sg5
S'PMC2606836'
p3207
sg7
g3187
sg9
V18931095.xml
p3208
sa(dp3209
g3
VSTD-Melfsen-2011
p3210
sg5
S'PMC3058082'
p3211
sg7
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p3212
sg9
V21356037.xml
p3213
sa(dp3214
g3
VSTD-T_x00f8_nnesen-2012
p3215
sg5
S'PMC3432241'
p3216
sg7
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p3217
sg9
V22323576.xml
p3218
sa(dp3219
g3
VSTD-Rosenstock-2008
p3220
sg5
S'PMC2235909'
p3221
sg7
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p3222
sg9
V18204830.xml
p3223
sa(dp3224
g3
VSTD-Swinnen-2010a
p3225
sg5
S'PMC2875419'
p3226
sg7
g3222
sg9
V20200301.xml
p3227
sa(dp3228
g3
VSTD-Villanueva-2001
p3229
sg5
S'PMC59901'
p3230
sg7
VCD007335 v. 3.0 Interventions to improve question formulation in professional practice and self-directed learning.rm5
p3231
sg9
V11716797.xml
p3232
sa(dp3233
g3
VSTD-SU.FOL.OM3-2010
p3234
sg5
S'PMC2993045'
p3235
sg7
VCD006612 v. 4.0 Homocysteine-lowering interventions for preventing cardiovascular events.rm5
p3236
sg9
V21115589.xml
p3237
sa(dp3238
g3
VSTD-Westerbeek-2010
p3239
sg5
S'PMC2579424'
p3240
sg7
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p3241
sg9
V18947426.xml
p3242
sa(dp3243
g3
VSTD-Emet-2004
p3244
sg5
S'PMC522835'
p3245
sg7
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p3246
sg9
V15312215.xml
p3247
sa(dp3248
g3
VSTD-_x0032_-VA-Aubin-2008
p3249
sg5
S'PMC2569194'
p3250
sg7
VCD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
p3251
sg9
V18263663.xml
p3252
sa(dp3253
g3
VSTD-Kuijper-2009
p3254
sg5
S'PMC2758937'
p3255
sg7
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p3256
sg9
V19812130.xml
p3257
sa(dp3258
g3
VSTD-Martel-2011
p3259
sg5
S'PMC3045999'
p3260
sg7
g3256
sg9
V21303529.xml
p3261
sa(dp3262
g3
VSTD-Str_x00f6_hlein-2009
p3263
sg5
S'PMC2644666'
p3264
sg7
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p3265
sg9
V19216794.xml
p3266
sa(dp3267
g3
VSTD-Manegold-2003
p3268
sg5
S'PMC2361263'
p3269
sg7
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p3270
sg9
V16641904.xml
p3271
sa(dp3272
g3
VSTD-van-der-Kooi-2007
p3273
sg5
S'PMC2779375'
p3274
sg7
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p3275
sg9
V17361345.xml
p3276
sa(dp3277
g3
VSTD-Gregson-2007
p3278
sg5
S'PMC1831737'
p3279
sg7
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p3280
sg9
V17388666.xml
p3281
sa(dp3282
g3
VSTD-Echeverry-2009
p3283
sg5
S'PMC2782968'
p3284
sg7
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p3285
sg9
V19729522.xml
p3286
sa(dp3287
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p3288
sg5
S'PMC1914073'
p3289
sg7
g3285
sg9
V17570858.xml
p3290
sa(dp3291
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p3292
sg5
S'PMC165418'
p3293
sg7
g3285
sg9
V12747810.xml
p3294
sa(dp3295
g3
VSTD-Xue-2004
p3296
sg5
S'PMC3772925'
p3297
sg7
g3285
sg9
V24058553.xml
p3298
sa(dp3299
g3
VSTD-van-Bastelaar-2011
p3300
sg5
S'PMC3024341'
p3301
sg7
g3285
sg9
V21216855.xml
p3302
sa(dp3303
g3
VSTD-Campbell-1991
p3304
sg5
S'PMC2448633'
p3305
sg7
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p3306
sg9
V1853495.xml
p3307
sa(dp3308
g3
VSTD-Dabbous-1998
p3309
sg5
S'PMC3015295'
p3310
sg7
g3306
sg9
V9876753.xml
p3311
sa(dp3312
g3
VSTD-ThanMYA91
p3313
sg5
S'PMC3688502'
p3314
sg7
VCD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
p3315
sg9
V23818874.xml
p3316
sa(dp3317
g3
VSTD-ThanMYA97
p3318
sg5
S'PMC3688502'
p3319
sg7
g3315
sg9
V23818874.xml
p3320
sa(dp3321
g3
VSTD-ThanMYA93b
p3322
sg5
S'PMC3688502'
p3323
sg7
g3315
sg9
V23818874.xml
p3324
sa(dp3325
g3
VSTD-ThanMYA93c
p3326
sg5
S'PMC3688502'
p3327
sg7
g3315
sg9
V23818874.xml
p3328
sa(dp3329
g3
VSTD-ThanMYA93a
p3330
sg5
S'PMC3688502'
p3331
sg7
g3315
sg9
V23818874.xml
p3332
sa(dp3333
g3
VSTD-ThanMYA96a
p3334
sg5
S'PMC3688502'
p3335
sg7
g3315
sg9
V23818874.xml
p3336
sa(dp3337
g3
VSTD-ThanMYA94a
p3338
sg5
S'PMC3688502'
p3339
sg7
g3315
sg9
V23818874.xml
p3340
sa(dp3341
g3
VSTD-ThanMYA90_x002d_91
p3342
sg5
S'PMC3688502'
p3343
sg7
g3315
sg9
V23818874.xml
p3344
sa(dp3345
g3
VSTD-_x0030_13-Papanikolaou-2004
p3346
sg5
S'PMC524504'
p3347
sg7
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p3348
sg9
V15450119.xml
p3349
sa(dp3350
g3
VSTD-FinHer
p3351
sg5
S'PMC2860103'
p3352
sg7
VCD004421 v. 8.0 Taxanes for adjuvant treatment of early breast cancer.rm5
p3353
sg9
V19819914.xml
p3354
sa(dp3355
g3
VSTD-RIOTT-2010
p3356
sg5
S'PMC1613238'
p3357
sg7
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p3358
sg9
V17002810.xml
p3359
sa(dp3360
g3
VSTD-McElhinney-2000
p3361
sg5
S'PMC2449154'
p3362
sg7
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p3363
sg9
V10881642.xml
p3364
sa(dp3365
g3
VSTD-Strychar-2009
p3366
sg5
S'PMC2732152'
p3367
sg7
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p3368
sg9
V19542011.xml
p3369
sa(dp3370
g3
VSTD-Zafar-2008
p3371
sg5
S'PMC3734022'
p3372
sg7
VCD000947 v. 8.0 Continuous and interrupted suturing techniques for repair of episiotomy or second-degree tears.rm5
p3373
sg9
V24059980.xml
p3374
sa(dp3375
g3
VSTD-Barrowman-2003
p3376
sg5
S'PMC212708'
p3377
sg7
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p3378
sg9
V12877755.xml
p3379
sa(dp3380
g3
VSTD-Weller-1998
p3381
sg5
S'PMC3314787'
p3382
sg7
g3378
sg9
V22415239.xml
p3383
sa(dp3384
g3
VSTD-Neuhaus-2009
p3385
sg5
S'PMC2634726'
p3386
sg7
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p3387
sg9
V19127261.xml
p3388
sa(dp3389
g3
VSTD-McKay-2008
p3390
sg5
S'PMC2630830'
p3391
sg7
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p3392
sg9
V19017582.xml
p3393
sa(dp3394
g3
VSTD-Kylmala-1997
p3395
sg5
S'PMC2228066'
p3396
sg7
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p3397
sg9
V9328156.xml
p3398
sa(dp3399
g3
VSTD-Mustafa-2002
p3400
sg5
S'PMC3366228'
p3401
sg7
VCD005455 v. 4.0 Choice of instruments for assisted vaginal delivery.rm5
p3402
sg9
V22685661.xml
p3403
sa(dp3404
g3
VSTD-Opiyo-2008
p3405
sg5
S'PMC2229665'
p3406
sg7
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p3407
sg9
V18270586.xml
p3408
sa(dp3409
g3
VSTD-Sculier-2001
p3410
sg5
S'PMC2363948'
p3411
sg7
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p3412
sg9
V11720426.xml
p3413
sa(dp3414
g3
VSTD-Vedder-2007
p3415
sg5
S'PMC1913555'
p3416
sg7
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p3417
sg9
V17622343.xml
p3418
sa(dp3419
g3
VSTD-Westlake-2009
p3420
sg5
S'PMC2708184'
p3421
sg7
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p3422
sg9
V19523207.xml
p3423
sa(dp3424
g3
VSTD-Gill-2011
p3425
sg5
S'PMC3032994'
p3426
sg7
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p3427
sg9
V21292711.xml
p3428
sa(dp3429
g3
VSTD-ASTEC_x002f_EN.5
p3430
sg5
S'PMC2646125'
p3431
sg7
VCD003916 v. 7.1 Adjuvant radiotherapy for stage I endometrial cancer.rm5
p3432
sg9
V19070891.xml
p3433
sa(dp3434
g3
VSTD-Mehta-2007
p3435
sg5
S'PMC2131759'
p3436
sg7
VCD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
p3437
sg9
V17974032.xml
p3438
sa(dp3439
g3
VSTD-Kercsmar-2006
p3440
sg5
S'PMC1626393'
p3441
sg7
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p3442
sg9
V17035145.xml
p3443
sa(dp3444
g3
VSTD-Bhardwaj-1994
p3445
sg5
S'PMC3590536'
p3446
sg7
VCD002006 v. 10.0 Position in the second stage of labour for women without epidural anaesthesia.rm5
p3447
sg9
V23492921.xml
p3448
sa(dp3449
g3
VSTD-Cremin-2010
p3450
sg5
S'PMC2865634'
p3451
sg7
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p3452
sg9
V19623481.xml
p3453
sa(dp3454
g3
VSTD-Swoboda-2010
p3455
sg5
S'PMC2924376'
p3456
sg7
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p3457
sg9
V20808854.xml
p3458
sa(dp3459
g3
VSTD-Schiff-2008
p3460
sg5
S'PMC2564802'
p3461
sg7
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p3462
sg9
V18055472.xml
p3463
sa(dp3464
g3
VSTD-Xia-2002-_x0028_CPZ_x0029_
p3465
sg5
S'PMC3745831'
p3466
sg7
VCD000059 v. 12.0 Clozapine versus typical neuroleptic medication for schizophrenia.rm5
p3467
sg9
V23984190.xml
p3468
sa(dp3469
g3
VSTD-Combe-2006
p3470
sg5
S'PMC2689524'
p3471
sg7
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p3472
sg9
V18794178.xml
p3473
sa(dp3474
g3
VSTD-Ietswaart-2011
p3475
sg5
S'PMC3097892'
p3476
sg7
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p3477
sg9
V21515905.xml
p3478
sa(dp3479
g3
VSTD-Yun-2010
p3480
sg5
S'PMC3309215'
p3481
sg7
g3477
sg9
V22506139.xml
p3482
sa(dp3483
g3
VSTD-Hurley-2007
p3484
sg5
S'PMC2673355'
p3485
sg7
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p3486
sg9
V17907147.xml
p3487
sa(dp3488
g3
VSTD-Nour-2006
p3489
sg5
S'PMC1525193'
p3490
sg7
g3486
sg9
V16734904.xml
p3491
sa(dp3492
g3
VSTD-Ersek-2004
p3493
sg5
S'PMC509247'
p3494
sg7
g3486
sg9
V15285783.xml
p3495
sa(dp3496
g3
VSTD-Smeets-2006
p3497
sg5
S'PMC1382224'
p3498
sg7
g3486
sg9
V16426449.xml
p3499
sa(dp3500
g3
VSTD-Forsetlund-2003
p3501
sg5
S'PMC153535'
p3502
sg7
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p3503
sg9
V12694632.xml
p3504
sa(dp3505
g3
VSTD-Chappell-2008
p3506
sg5
S'PMC2840539'
p3507
sg7
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p3508
sg9
V20428412.xml
p3509
sa(dp3510
g3
VSTD-Pfizer588
p3511
sg5
S'PMC2955947'
p3512
sg7
VCD002795 v. 8.0 Pharmacotherapy for post traumatic stress disorder (PTSD).rm5
p3513
sg9
V21407853.xml
p3514
sa(dp3515
g3
VSTD-Pfizer589
p3516
sg5
S'PMC2955947'
p3517
sg7
g3513
sg9
V21407853.xml
p3518
sa(dp3519
g3
VSTD-Smithuis-2010
p3520
sg5
S'PMC2947715'
p3521
sg7
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p3522
sg9
V20832366.xml
p3523
sa(dp3524
g3
VSTD-Kolaczinski-2012
p3525
sg5
S'PMC3269419'
p3526
sg7
g3522
sg9
V22303437.xml
p3527
sa(dp3528
g3
VSTD-El_x002d_Sayed-2007
p3529
sg5
S'PMC2111052'
p3530
sg7
g3522
sg9
V18074034.xml
p3531
sa(dp3532
g3
VSTD-Ledermann-2006
p3533
sg5
S'PMC1665467'
p3534
sg7
g3522
sg9
V17105658.xml
p3535
sa(dp3536
g3
VSTD-Shekalaghe-2007
p3537
sg5
S'PMC1995753'
p3538
sg7
g3522
sg9
V17925871.xml
p3539
sa(dp3540
g3
VSTD-Mistiaen-2009
p3541
sg5
S'PMC2924330'
p3542
sg7
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p3543
sg9
V20687915.xml
p3544
sa(dp3545
g3
VSTD-PITCH-2012
p3546
sg5
S'PMC3420230'
p3547
sg7
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p3548
sg9
V22695903.xml
p3549
sa(dp3550
g3
VSTD-CLOTS-2009
p3551
sg5
S'PMC2692021'
p3552
sg7
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p3553
sg9
V19477503.xml
p3554
sa(dp3555
g3
VSTD-Mok-2007
p3556
sg5
S'PMC2656338'
p3557
sg7
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p3558
sg9
V19300631.xml
p3559
sa(dp3560
g3
VSTD-Carlini-2012
p3561
sg5
S'PMC3438078'
p3562
sg7
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p3563
sg9
V22768793.xml
p3564
sa(dp3565
g3
VSTD-McClure-2006
p3566
sg5
S'PMC2018826'
p3567
sg7
g3563
sg9
V16954124.xml
p3568
sa(dp3569
g3
VSTD-Binnie-2007
p3570
sg5
S'PMC1871574'
p3571
sg7
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p3572
sg9
V17475005.xml
p3573
sa(dp3574
g3
VSTD-Brandstein-2011
p3575
sg5
S'PMC3453521'
p3576
sg7
g3572
sg9
V22853197.xml
p3577
sa(dp3578
g3
VSTD-_x00c5_gren-2011
p3579
sg5
S'PMC3233272'
p3580
sg7
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p3581
sg9
V22066891.xml
p3582
sa(dp3583
g3
VSTD-Bennell-2010
p3584
sg5
S'PMC2830179'
p3585
sg7
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p3586
sg9
V20163739.xml
p3587
sa(dp3588
g3
VSTD-Morgan-2010
p3589
sg5
S'PMC3639680'
p3590
sg7
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p3591
sg9
V21131037.xml
p3592
sa(dp3593
g3
VSTD-Jepson-2010
p3594
sg5
S'PMC2944371'
p3595
sg7
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p3596
sg9
V20825660.xml
p3597
sa(dp3598
g3
VSTD-Bambra-2010
p3599
sg5
S'PMC2921286'
p3600
sg7
g3596
sg9
V19692738.xml
p3601
sa(dp3602
g3
VSTD-Darmstadt-2009
p3603
sg5
S'PMC2679412'
p3604
sg7
g3596
sg9
V19426469.xml
p3605
sa(dp3606
g3
VSTD-Main-2008
p3607
sg5
S'PMC2412872'
p3608
sg7
g3596
sg9
V18505545.xml
p3609
sa(dp3610
g3
VSTD-Yakoob-2009
p3611
sg5
S'PMC2679409'
p3612
sg7
g3596
sg9
V19426466.xml
p3613
sa(dp3614
g3
VSTD-Menezes-2009
p3615
sg5
S'PMC2679410'
p3616
sg7
g3596
sg9
V19426467.xml
p3617
sa(dp3618
g3
VSTD-Haws-2009
p3619
sg5
S'PMC2679411'
p3620
sg7
g3596
sg9
V19426468.xml
p3621
sa(dp3622
g3
VSTD-Shea-2009
p3623
sg5
S'PMC3226237'
p3624
sg7
g3596
sg9
V19828063.xml
p3625
sa(dp3626
g3
VSTD-Bhutta-2009
p3627
sg5
S'PMC2679413'
p3628
sg7
g3596
sg9
V19426470.xml
p3629
sa(dp3630
g3
VSTD-Barros-2010
p3631
sg5
S'PMC2841444'
p3632
sg7
g3596
sg9
V20233384.xml
p3633
sa(dp3634
g3
VSTD-Collins-2008a
p3635
sg5
S'PMC2572211'
p3636
sg7
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p3637
sg9
V18952682.xml
p3638
sa(dp3639
g3
VSTD-Yeka-2007-UGA
p3640
sg5
S'PMC2405936'
p3641
sg7
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p3642
sg9
V18545692.xml
p3643
sa(dp3644
g3
VSTD-Adjei-2006-GHA
p3645
sg5
S'PMC2478668'
p3646
sg7
g3642
sg9
V18620577.xml
p3647
sa(dp3648
g3
VSTD-Van-den-Broek-2004-ZAR
p3649
sg5
S'PMC1697822'
p3650
sg7
g3642
sg9
V17125496.xml
p3651
sa(dp3652
g3
VSTD-Yeka-2004-UGA
p3653
sg5
S'PMC1181876'
p3654
sg7
g3642
sg9
V16033307.xml
p3655
sa(dp3656
g3
VSTD-Faye-2003-SEN
p3657
sg5
S'PMC1919387'
p3658
sg7
g3642
sg9
V17570848.xml
p3659
sa(dp3660
g3
VSTD-Grande-2005-PER
p3661
sg5
S'PMC2040506'
p3662
sg7
g3642
sg9
V17971864.xml
p3663
sa(dp3664
g3
VSTD-Mukhtar-2005-SDN
p3665
sg5
S'PMC1940006'
p3666
sg7
g3642
sg9
V17631681.xml
p3667
sa(dp3668
g3
VSTD-Kobbe-2007-GHA
p3669
sg5
S'PMC2625364'
p3670
sg7
g3642
sg9
V19099594.xml
p3671
sa(dp3672
g3
VSTD-Kamya-2006-UGA
p3673
sg5
S'PMC1876597'
p3674
sg7
g3642
sg9
V17525792.xml
p3675
sa(dp3676
g3
VSTD-Mens-2007-KEN
p3677
sg5
S'PMC2600646'
p3678
sg7
g3642
sg9
V19017387.xml
p3679
sa(dp3680
g3
VSTD-Bonnet-2004-GIN
p3681
sg5
S'PMC1868032'
p3682
sg7
g3642
sg9
V17477865.xml
p3683
sa(dp3684
g3
VSTD-Bukirwa-2005-UGA
p3685
sg5
S'PMC1488893'
p3686
sg7
g3642
sg9
V16871329.xml
p3687
sa(dp3688
g3
VSTD-Hutagalung-2002-THA
p3689
sg5
S'PMC1261533'
p3690
sg7
g3642
sg9
V16179089.xml
p3691
sa(dp3692
g3
VSTD-Menard-2006-MDG
p3693
sg5
S'PMC1887535'
p3694
sg7
g3642
sg9
V17519010.xml
p3695
sa(dp3696
g3
VSTD-Owusu_x002d_Agyei-2006-GHA
p3697
sg5
S'PMC2430614'
p3698
sg7
g3642
sg9
V18575626.xml
p3699
sa(dp3700
g3
VSTD-Kayentao-2006-MLI
p3701
sg5
S'PMC2631542'
p3702
sg7
g3642
sg9
V19128455.xml
p3703
sa(dp3704
g3
VSTD-Fang-1995
p3705
sg5
S'PMC3487803'
p3706
sg7
VCD004921 v. 5.0 Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.rm5
p3707
sg9
V22937790.xml
p3708
sa(dp3709
g3
VSTD-Sangdee-2002-_x002a_
p3710
sg5
S'PMC102323'
p3711
sg7
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p3712
sg9
V11914160.xml
p3713
sa(dp3714
g3
VSTD-Sangdee-2002-_x002a__x002a_
p3715
sg5
S'PMC102323'
p3716
sg7
g3712
sg9
V11914160.xml
p3717
sa(dp3718
g3
VSTD-Assadi-2003
p3719
sg5
S'PMC293465'
p3720
sg7
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p3721
sg9
V14624703.xml
p3722
sa(dp3723
g3
VSTD-Nachum-2010
p3724
sg5
S'PMC2988803'
p3725
sg7
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p3726
sg9
V21054896.xml
p3727
sa(dp3728
g3
VSTD-Arun-2008
p3729
sg5
S'PMC2772000'
p3730
sg7
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p3731
sg9
V19902034.xml
p3732
sa(dp3733
g3
VSTD-Zwarenstein-2007
p3734
sg5
S'PMC2200659'
p3735
sg7
g3731
sg9
V17892588.xml
p3736
sa(dp3737
g3
VSTD-Quadri-1980
p3738
sg5
S'PMC3013310'
p3739
sg7
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p3740
sg9
V22058460.xml
p3741
sa(dp3742
g3
VSTD-Avril-1997
p3743
sg5
S'PMC2223779'
p3744
sg7
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p3745
sg9
V9218740.xml
p3746
sa(dp3747
g3
VSTD-Nafisi-2006
p3748
sg5
S'PMC1764008'
p3749
sg7
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p3750
sg9
V17176461.xml
p3751
sa(dp3752
g3
VSTD-Zehnder-2010
p3753
sg5
S'PMC2841102'
p3754
sg7
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p3755
sg9
V20181120.xml
p3756
sa(dp3757
g3
VSTD-Ghana-2009
p3758
sg5
S'PMC2928084'
p3759
sg7
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p3760
sg9
V19902797.xml
p3761
sa(dp3762
g3
VSTD-Kapoor-1996
p3763
sg5
S'PMC2443081'
p3764
sg7
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p3765
sg9
V8725454.xml
p3766
sa(dp3767
g3
VSTD-Br_x00f8_nfort-1989
p3768
sg5
S'PMC2841070'
p3769
sg7
VCD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
p3770
sg9
V20184717.xml
p3771
sa(dp3772
g3
VSTD-Yip-2011
p3773
sg5
S'PMC3221969'
p3774
sg7
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p3775
sg9
V21269484.xml
p3776
sa(dp3777
g3
VSTD-Prasad-2011
p3778
sg5
S'PMC3191816'
p3779
sg7
g3775
sg9
V22007348.xml
p3780
sa(dp3781
g3
VSTD-Matsumoto-2002
p3782
sg5
S'PMC2375187'
p3783
sg7
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p3784
sg9
V11870500.xml
p3785
sa(dp3786
g3
VSTD-MCG-2001
p3787
sg5
S'PMC2375253'
p3788
sg7
VCD003139 v. 10.0 High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
p3789
sg9
V11720455.xml
p3790
sa(dp3791
g3
VSTD-LOTUS-Trial-2008
p3792
sg5
S'PMC2565581'
p3793
sg7
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p3794
sg9
V18469091.xml
p3795
sa(dp3796
g3
VSTD-Begley-2009
p3797
sg5
S'PMC3226589'
p3798
sg7
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p3799
sg9
V22035427.xml
p3800
sa(dp3801
g3
VSTD-Bernitz-2011
p3802
sg5
S'PMC3187863'
p3803
sg7
g3799
sg9
V21749629.xml
p3804
sa(dp3805
g3
VSTD-Scalambrino-1989
p3806
sg5
S'PMC1852268'
p3807
sg7
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p3808
sg9
V12839630.xml
p3809
sa(dp3810
g3
VSTD-Chatwani-1997
p3811
sg5
S'PMC2364549'
p3812
sg7
g3808
sg9
V18476152.xml
p3813
sa(dp3814
g3
VSTD-Chatwani-1995
p3815
sg5
S'PMC2364413'
p3816
sg7
g3808
sg9
V18475417.xml
p3817
sa(dp3818
g3
VSTD-Roy-2003
p3819
sg5
S'PMC1852268'
p3820
sg7
g3808
sg9
V12839630.xml
p3821
sa(dp3822
g3
VSTD-van-der-Roer-2008
p3823
sg5
S'PMC2527421'
p3824
sg7
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p3825
sg9
V18663487.xml
p3826
sa(dp3827
g3
VSTD-Strong-1998
p3828
sg5
S'PMC3617092'
p3829
sg7
g3825
sg9
V23537369.xml
p3830
sa(dp3831
g3
VSTD-Smeets-2006
p3832
sg5
S'PMC1382224'
p3833
sg7
g3825
sg9
V16426449.xml
p3834
sa(dp3835
g3
VSTD-Nakakura-2012
p3836
sg5
S'PMC3299559'
p3837
sg7
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p3838
sg9
V22419858.xml
p3839
sa(dp3840
g3
VSTD-Lazo-2010
p3841
sg5
S'PMC2945152'
p3842
sg7
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p3843
sg9
V20664019.xml
p3844
sa(dp3845
g3
VSTD-Harms-2008
p3846
sg5
S'PMC2373885'
p3847
sg7
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p3848
sg9
V18478129.xml
p3849
sa(dp3850
g3
VSTD-Begley-2008
p3851
sg5
S'PMC2443289'
p3852
sg7
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p3853
sg9
V18628946.xml
p3854
sa(dp3855
g3
VSTD-McDaid-2010
p3856
sg5
S'PMC3010905'
p3857
sg7
g3853
sg9
V20595141.xml
p3858
sa(dp3859
g3
VSTD-Mor-2007-_x0028_HIV_x002d_pos_x0029_
p3860
sg5
S'PMC1955830'
p3861
sg7
g3853
sg9
V17848992.xml
p3862
sa(dp3863
g3
VSTD-Mor-2007
p3864
sg5
S'PMC1955830'
p3865
sg7
g3853
sg9
V17848992.xml
p3866
sa(dp3867
g3
VSTD-Mor-2007-_x0028_HIV_x002d_neg_x0029_
p3868
sg5
S'PMC1955830'
p3869
sg7
g3853
sg9
V17848992.xml
p3870
sa(dp3871
g3
VSTD-Lane-2011
p3872
sg5
S'PMC2888758'
p3873
sg7
g3853
sg9
V19662523.xml
p3874
sa(dp3875
g3
VSTD-Abeku-2008a
p3876
sg5
S'PMC2571107'
p3877
sg7
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p3878
sg9
V18834523.xml
p3879
sa(dp3880
g3
VSTD-Abeku-2008b
p3881
sg5
S'PMC2571107'
p3882
sg7
g3878
sg9
V18834523.xml
p3883
sa(dp3884
g3
VSTD-Kyabayinze-2008
p3885
sg5
S'PMC2584069'
p3886
sg7
g3878
sg9
V18959777.xml
p3887
sa(dp3888
g3
VSTD-Msellem-2009
p3889
sg5
S'PMC2667629'
p3890
sg7
g3878
sg9
V19399156.xml
p3891
sa(dp3892
g3
VSTD-Bharti-2008
p3893
sg5
S'PMC2478667'
p3894
sg7
g3878
sg9
V18620560.xml
p3895
sa(dp3896
g3
VSTD-Zhang-2004
p3897
sg5
S'PMC3522714'
p3898
sg7
VCD007028 v. 3.2 Mailuoning for acute ischaemic stroke.rm5
p3899
sg9
V23272146.xml
p3900
sa(dp3901
g3
VSTD-Arezzo-2008
p3902
sg5
S'PMC2565674'
p3903
sg7
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p3904
sg9
V18796160.xml
p3905
sa(dp3906
g3
VSTD-Choo-2008
p3907
sg5
S'PMC2680337'
p3908
sg7
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p3909
sg9
V19143854.xml
p3910
sa(dp3911
g3
VSTD-L-_x002d_-LEAD-1-Marre-2009
p3912
sg5
S'PMC2871176'
p3913
sg7
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p3914
sg9
V19317822.xml
p3915
sa(dp3916
g3
VSTD-Lixi-_x002d_-Ratner-2010
p3917
sg5
S'PMC3068287'
p3918
sg7
g3914
sg9
V20722676.xml
p3919
sa(dp3920
g3
VSTD-T-_x002d_-Nauck-2009
p3921
sg5
S'PMC2699710'
p3922
sg7
g3914
sg9
V19366970.xml
p3923
sa(dp3924
g3
VSTD-A-_x002d_-Rosenstock-2009
p3925
sg5
S'PMC2752910'
p3926
sg7
g3914
sg9
V19592625.xml
p3927
sa(dp3928
g3
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p3929
sg5
S'PMC2606836'
p3930
sg7
g3914
sg9
V18931095.xml
p3931
sa(dp3932
g3
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p3933
sg5
S'PMC2744824'
p3934
sg7
g3914
sg9
V19688338.xml
p3935
sa(dp3936
g3
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p3937
sg5
S'PMC2699702'
p3938
sg7
g3914
sg9
V19289857.xml
p3939
sa(dp3940
g3
VSTD-T_x002d_-Ratner-2010
p3941
sg5
S'PMC2948428'
p3942
sg7
g3914
sg9
V20536952.xml
p3943
sa(dp3944
g3
VSTD-Bateman-2006
p3945
sg5
S'PMC1386666'
p3946
sg7
VCD002308 v. 8.18 Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.rm5
p3947
sg9
V16433920.xml
p3948
sa(dp3949
g3
VSTD-Feste-2000
p3950
sg5
S'PMC3015351'
p3951
sg7
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p3952
sg9
V10772522.xml
p3953
sa(dp3954
g3
VSTD-Venkatesh-2007
p3955
sg5
S'PMC3015718'
p3956
sg7
g3952
sg9
V17761080.xml
p3957
sa(dp3958
g3
VSTD-Wells-2004
p3959
sg5
S'PMC2364768'
p3960
sg7
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p3961
sg9
V15238983.xml
p3962
sa(dp3963
g3
VSTD-King-2009
p3964
sg5
S'PMC2634705'
p3965
sg7
g3961
sg9
V19107130.xml
p3966
sa(dp3967
g3
VSTD-Wattchow-2006
p3968
sg5
S'PMC2361245'
p3969
sg7
g3961
sg9
V16622437.xml
p3970
sa(dp3971
g3
VSTD-Hanks-2002
p3972
sg5
S'PMC2364271'
p3973
sg7
g3961
sg9
V12232756.xml
p3974
sa(dp3975
g3
VSTD-Hochreiter-2009
p3976
sg5
S'PMC2717450'
p3977
sg7
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p3978
sg9
V19493352.xml
p3979
sa(dp3980
g3
VSTD-Brown-2001
p3981
sg5
S'PMC2375236'
p3982
sg7
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p3983
sg9
V11720460.xml
p3984
sa(dp3985
g3
VSTD-Brown-1999
p3986
sg5
S'PMC2363012'
p3987
sg7
g3983
sg9
V10390003.xml
p3988
sa(dp3989
g3
VSTD-Ramakrishna-2008
p3990
sg5
S'PMC2217593'
p3991
sg7
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p3992
sg9
V18270575.xml
p3993
sa(dp3994
g3
VSTD-Juvenile-2009
p3995
sg5
S'PMC2945155'
p3996
sg7
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p3997
sg9
V20696865.xml
p3998
sa(dp3999
g3
VSTD-Raccah-2009
p4000
sg5
S'PMC2782985'
p4001
sg7
g3997
sg9
V19767384.xml
p4002
sa(dp4003
g3
VSTD-Battelino-2011
p4004
sg5
S'PMC3064030'
p4005
sg7
g3997
sg9
V21335621.xml
p4006
sa(dp4007
g3
VSTD-Luckner-2006
p4008
sg5
S'PMC1550871'
p4009
sg7
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p4010
sg9
V16542484.xml
p4011
sa(dp4012
g3
VSTD-Morelli-2008b
p4013
sg5
S'PMC2646303'
p4014
sg7
g4010
sg9
V19017409.xml
p4015
sa(dp4016
g3
VSTD-Seguin-2006
p4017
sg5
S'PMC1550826'
p4018
sg7
g4010
sg9
V16507156.xml
p4019
sa(dp4020
g3
VSTD-Morelli-2009
p4021
sg5
S'PMC2750187'
p4022
sg7
g4010
sg9
V19664253.xml
p4023
sa(dp4024
g3
VSTD-Fraser-1993
p4025
sg5
S'PMC1968186'
p4026
sg7
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p4027
sg9
V8431375.xml
p4028
sa(dp4029
g3
VSTD-Harper_x002d_Wynne-1999
p4030
sg5
S'PMC2362871'
p4031
sg7
g4027
sg9
V10496359.xml
p4032
sa(dp4033
g3
VSTD-Karabay-2004
p4034
sg5
S'PMC459220'
p4035
sg7
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p4036
sg9
V15214959.xml
p4037
sa(dp4038
g3
VSTD-Lumley-2006
p4039
sg5
S'PMC1479326'
p4040
sg7
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p4041
sg9
V16483383.xml
p4042
sa(dp4043
g3
VSTD-Dennis-2009
p4044
sg5
S'PMC2628301'
p4045
sg7
g4041
sg9
V19147637.xml
p4046
sa(dp4047
g3
VSTD-Gilbert-2008
p4048
sg5
S'PMC2292251'
p4049
sg7
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p4050
sg9
V18431475.xml
p4051
sa(dp4052
g3
VSTD-Girish-2003
p4053
sg5
S'PMC2951534'
p4054
sg7
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p4055
sg9
V21206808.xml
p4056
sa(dp4057
g3
VSTD-Agarwal-1985
p4058
sg5
S'PMC3011123'
p4059
sg7
g4055
sg9
V21927109.xml
p4060
sa(dp4061
g3
VSTD-Bagadia-1981
p4062
sg5
S'PMC3012902'
p4063
sg7
g4055
sg9
V22058556.xml
p4064
sa(dp4065
g3
VSTD-Janakiramiah-1981
p4066
sg5
S'PMC3012948'
p4067
sg7
g4055
sg9
V22058544.xml
p4068
sa(dp4069
g3
VSTD-Peterson-2007
p4070
sg5
S'PMC1876601'
p4071
sg7
VCD007189 v. 4.9 Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.rm5
p4072
sg9
V17525796.xml
p4073
sa(dp4074
g3
VSTD-Brazil-2000a
p4075
sg5
S'PMC3611911'
p4076
sg7
VCD002252 v. 8.0 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
p4077
sg9
V23560009.xml
p4078
sa(dp4079
g3
VSTD-Jordan-2003
p4080
sg5
S'PMC1241771'
p4081
sg7
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p4082
sg9
V14644671.xml
p4083
sa(dp4084
g3
VSTD-Symonds-1996
p4085
sg5
S'PMC2074575'
p4086
sg7
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p4087
sg9
V8688343.xml
p4088
sa(dp4089
g3
VSTD-Stokman-2003
p4090
sg5
S'PMC2376383'
p4091
sg7
g4087
sg9
V12671696.xml
p4092
sa(dp4093
g3
VSTD-Jebb-1994
p4094
sg5
S'PMC2033386'
p4095
sg7
g4087
sg9
V7917930.xml
p4096
sa(dp4097
g3
VSTD-Mills-1988
p4098
sg5
S'PMC2246575'
p4099
sg7
g4087
sg9
V3390377.xml
p4100
sa(dp4101
g3
VSTD-Hartmann-2001
p4102
sg5
S'PMC2363753'
p4103
sg7
g4087
sg9
V11161394.xml
p4104
sa(dp4105
g3
VSTD-START-A-2008
p4106
sg5
S'PMC2323709'
p4107
sg7
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p4108
sg9
V18356109.xml
p4109
sa(dp4110
g3
VSTD-Vargas-2005
p4111
sg5
S'PMC1269449'
p4112
sg7
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p4113
sg9
V16137351.xml
p4114
sa(dp4115
g3
VSTD-N_x00e1_polis-2011
p4116
sg5
S'PMC3071998'
p4117
sg7
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p4118
sg9
V21552662.xml
p4119
sa(dp4120
g3
VSTD-Nilsson-2009
p4121
sg5
S'PMC2760502'
p4122
sg7
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p4123
sg9
V19781053.xml
p4124
sa(dp4125
g3
VSTD-Ferrer-2005
p4126
sg5
S'PMC3666262'
p4127
sg7
VCD006911 v. 6.0 Music interventions for improving psychological and physical outcomes in cancer patients.rm5
p4128
sg9
V23741635.xml
p4129
sa(dp4130
g3
VSTD-Wahl-2008
p4131
sg5
S'PMC2573879'
p4132
sg7
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p4133
sg9
V18831749.xml
p4134
sa(dp4135
g3
VSTD-Mansour-2011
p4136
sg5
S'PMC3233274'
p4137
sg7
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p4138
sg9
V21995590.xml
p4139
sa(dp4140
g3
VSTD-Hwang-2008
p4141
sg5
S'PMC2615347'
p4142
sg7
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p4143
sg9
V18581595.xml
p4144
sa(dp4145
g3
VSTD-Vadiraja-2009b
p4146
sg5
S'PMC2933732'
p4147
sg7
g4143
sg9
V20842268.xml
p4148
sa(dp4149
g3
VSTD-Adamsen-2009
p4150
sg5
S'PMC2762035'
p4151
sg7
g4143
sg9
V19826172.xml
p4152
sa(dp4153
g3
VSTD-Oh-2010
p4154
sg5
S'PMC2826100'
p4155
sg7
g4143
sg9
V19880433.xml
p4156
sa(dp4157
g3
VSTD-Voerman-2007
p4158
sg5
S'PMC1915628'
p4159
sg7
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p4160
sg9
V17260162.xml
p4161
sa(dp4162
g3
VSTD-Hwang-2008
p4163
sg5
S'PMC2615347'
p4164
sg7
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p4165
sg9
V18581595.xml
p4166
sa(dp4167
g3
VSTD-Pan-XS-2010
p4168
sg5
S'PMC2553588'
p4169
sg7
VCD003711 v. 7.5 Herbal medicines for viral myocarditis.rm5
p4170
sg9
V18723572.xml
p4171
sa(dp4172
g3
VSTD-Carey-2005
p4173
sg5
S'PMC547907'
p4174
sg7
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p4175
sg9
V15667657.xml
p4176
sa(dp4177
g3
VSTD-Rabius-2008
p4178
sg5
S'PMC2630842'
p4179
sg7
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p4180
sg9
V19033146.xml
p4181
sa(dp4182
g3
VSTD-Stoddard-2008
p4183
sg5
S'PMC2630832'
p4184
sg7
g4180
sg9
V19097974.xml
p4185
sa(dp4186
g3
VSTD-Etter-2005
p4187
sg5
S'PMC1550632'
p4188
sg7
g4180
sg9
V15829474.xml
p4189
sa(dp4190
g3
VSTD-McKay-2008
p4191
sg5
S'PMC2630830'
p4192
sg7
g4180
sg9
V19017582.xml
p4193
sa(dp4194
g3
VSTD-Brendryen-2008a
p4195
sg5
S'PMC2630841'
p4196
sg7
g4180
sg9
V19087949.xml
p4197
sa(dp4198
g3
VSTD-Ding-1999
p4199
sg5
S'PMC3608539'
p4200
sg7
VCD008305 v. 3.3 Chinese herbal medicines for hypercholesterolemia.rm5
p4201
sg9
V23555827.xml
p4202
sa(dp4203
g3
VSTD-Magann-_x0028_M_x0029_-1993b
p4204
sg5
S'PMC2364670'
p4205
sg7
VCD000085 v. 5.0 Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.rm5
p4206
sg9
V18476211.xml
p4207
sa(dp4208
g3
VSTD-Magann-_x0028_S_x0029_-1993b
p4209
sg5
S'PMC2364670'
p4210
sg7
g4206
sg9
V18476211.xml
p4211
sa(dp4212
g3
VSTD-Carter-1970
p4213
sg5
S'PMC3327043'
p4214
sg7
VCD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
p4215
sg9
V22530180.xml
p4216
sa(dp4217
g3
VSTD-Hwang-2008
p4218
sg5
S'PMC2615347'
p4219
sg7
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p4220
sg9
V18581595.xml
p4221
sa(dp4222
g3
VSTD-Adamsen-2009
p4223
sg5
S'PMC2762035'
p4224
sg7
g4220
sg9
V19826172.xml
p4225
sa(dp4226
g3
VSTD-Oh-2010
p4227
sg5
S'PMC2826100'
p4228
sg7
g4220
sg9
V19880433.xml
p4229
sa(dp4230
g3
VSTD-Lepere-2000
p4231
sg5
S'PMC3015374'
p4232
sg7
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p4233
sg9
V10917122.xml
p4234
sa(dp4235
g3
VSTD-Bruggemann-2007
p4236
sg5
S'PMC1936417'
p4237
sg7
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p4238
sg9
V17612408.xml
p4239
sa(dp4240
g3
VSTD-Cascinu-1995
p4241
sg5
S'PMC2033463'
p4242
sg7
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p4243
sg9
V7819058.xml
p4244
sa(dp4245
g3
VSTD-Kikuchi-2006
p4246
sg5
S'PMC2360636'
p4247
sg7
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p4248
sg9
V16804523.xml
p4249
sa(dp4250
g3
VSTD-Hoshiyama-2002
p4251
sg5
S'PMC2364221'
p4252
sg7
g4248
sg9
V12177800.xml
p4253
sa(dp4254
g3
VSTD-Suzuki-2004
p4255
sg5
S'PMC2409667'
p4256
sg7
g4248
sg9
V15054454.xml
p4257
sa(dp4258
g3
VSTD-Key-1999
p4259
sg5
S'PMC2374337'
p4260
sg7
g4248
sg9
V10584890.xml
p4261
sa(dp4262
g3
VSTD-Li-2008
p4263
sg5
S'PMC2567088'
p4264
sg7
g4248
sg9
V18766189.xml
p4265
sa(dp4266
g3
VSTD-Wright-2008
p4267
sg5
S'PMC2440307'
p4268
sg7
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p4269
sg9
V18261131.xml
p4270
sa(dp4271
g3
VSTD-Baharvand-2010
p4272
sg5
S'PMC3232086'
p4273
sg7
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p4274
sg9
V22615593.xml
p4275
sa(dp4276
g3
VSTD-Osman-2010
p4277
sg5
S'PMC2922723'
p4278
sg7
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p4279
sg9
V19703826.xml
p4280
sa(dp4281
g3
VSTD-Kumar-2009
p4282
sg5
S'PMC2672933'
p4283
sg7
VCD005481 v. 4.4 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
p4284
sg9
V19358725.xml
p4285
sa.